The Point Values, Payment Of Health Care Covered By The Insurance For 2008

Original Language Title: Hodnoty bodu, úhrady zdravotní péče hrazené z pojištění pro r.2008

Read the untranslated law here: https://portal.gov.cz/app/zakony/download?idBiblio=65299&nr=383~2F2007~20Sb.&ft=txt

383/2007 Sb.



DECREE



of 19 December 2003. December 2007,



on the determination of the values of the point, the amount of the reimbursement of health care by

health insurance and regulatory limits on the volume provided by health

care paid for by public health insurance for the year 2008



The Ministry of health shall lay down pursuant to § 17 para. 6 of Act No. 48/1997

Coll., on public health insurance and amending and supplementing certain

related laws, as amended by Act No 117/2006 Coll., no 245/2006 Sb.

and no. 261/2007 Coll. (hereinafter the "Act"):



§ 1



(1) this Ordinance shall, for the year 2008, the point values, the amount of remittances

the health care provided to the insured under section 2 (2). 1 of the law (hereinafter

"insured person competent health insurance company") and the affiliated persons of the

the other Member States of the European Union, the European economic

area and Switzerland according to relevant regulations of the European

Community ^ 1) and the insured of other States with whom the United

Republic concluded international agreements on social security (^ 2)

"the beneficiary of EU"), paid for by public health insurance and

the regulatory limits on the volume of health care provided



and) in contractual healthcare facilities in institutional care, including

specialised therapeutic institutes for long-term patients, hospitals,

medical device reporting treatment day no. 00005 according

the Decree issuing the list of medical procedures with spot

the values of ^ 3) (hereinafter referred to as "power list"), and medical devices

the hospice type according to § 22a of the Act,



b) Contracting General practitioners for adults and for general practitioners

children and adolescents,



(c)) in contractual outpatient health care facilities providing

specialized outpatient medical care, including outpatient

health care facilities providing health care and hemodialysis

ortoptickou health care



d) Contracting dentists,



e) in contractual outpatient health care facilities providing

health care in the fields of medicine, 801, 802 222, 804, 805, 807, 809, 812-

819, 822 and 823, according to the list of services (hereinafter referred to as "listed

the skill "),



(f)) in contractual outpatient health care facilities providing

health care in the fields of medicine, 921 911 and 925, according to the list of performances



g) in contractual outpatient health care facilities providing

health care in 902 by the skill list of performances



h) Contracting healthcare emergency medical services,

medical transport and providing medical first aid service,



I) Contracting healthcare Spa care and ozdravovnami,



(j)) in the context of emergency care in non-medical

devices for methods of payment referred to in § 2 to 14.



(2) If a health care facility and a health insurance company agree on the

Another method of payment than stated in § 2 to 13, the agreed level of remuneration

under this method of payment must not be in conflict with health insurance

health insurance plan.



§ 2



For the health care provided by the medical devices specified in §

1 (1). 1 (b). a) to (j)), paid according to the list of performance shall be the

point value equal to 0.90 €, if not stipulated otherwise.



§ 3



(1) For health care provided by health establishments of the constitutional

care, with the exception of health care provided by specialised therapeutic

institutes, institutes for long-term patients in health care facilities

returning the treatment day no. 00005 according to the list of performances and in

Healthcare hospice type, point value, the amount of remittances

health care and regulatory restrictions set out in annex 1 to this

the Decree.



(2) For health care provided by specialised therapeutic institutes,

a sanatorium for long-term patients in health care facilities

returning the treatment day no. 00005 according to the list of performances and in

Healthcare hospice type, paid a flat rate per

one day of hospitalization, or according to the list of services, the value of point,

the amount of the reimbursement of health care and regulatory restrictions set out in annex 1 to the

This Decree.



§ 4



For the health care provided by general practitioners for adults and

General practitioners for children and adolescents, by the combined kapitačně

the performance payment, combined with kapitačně power payment

by calling kapitace or by list of performances, with the point value, the amount of

reimbursement of health care and regulatory restrictions set out in annex 2 to this

the Decree.



§ 5



For specialised outpatient healthcare provided in

outpatient healthcare facilities, paid for by list of performances

the value of the item, the amount of the reimbursement of health care and regulatory limits, determined by

in Appendix 3 to this notice.



§ 6



(1) for healthcare provided by dentists, paid by

list of performances, with a point value determined in § 2.



(2) health care dental non-referred to in paragraph

1 shall be paid in accordance with the contractual arrangement between the health insurance company and

medical facilities in accordance with the regulations on price control ^ 4).



(3) the health insurance fund shall be entitled to limit the total amount of payment

medical devices so that the total amount of remuneration for health care

provided by dentists in 2008 did not exceed the amount set out in the

health insurance plan health insurance health care

provided by dentists.



§ 7



For the health care provided by health establishments

in the listed fields of medicine, paid for by the lump-sum payment or according to the

list of performances, with the point value, the amount of the reimbursement of health care and regulatory

the restrictions set out in annex 4 to this notice.



§ 8



For the health care provided by health establishments

in the fields of medicine, 921 911 and 925 by list of performances, paid by

list of performances, with the point value, the amount of the reimbursement of health care and regulatory

the restrictions set out in annex 5 to this Decree.



§ 9



For the health care provided by health establishments

in 902 by the skill list of performances, paid according to the list of performances

the value of the item, the amount of the reimbursement of health care and regulatory limits, determined by

in annex 6 to this Ordinance.



§ 10



For healthcare provided in the framework of the emergency medical services,

paid by list of performance shall be the point value in the amount of € 1.03.



§ 11



For the performances of the medical transport, paid according to the list of services, the value of

point, the amount of the reimbursement of health care and regulatory restrictions set out in annex

# 7 of this Decree.



§ 12



For healthcare provided within the medical first-aid services,

paid by list of performance shall be the point value of 0.92 €.



section 13 of the



Spa care provided by health care facilities of Spa care, and

health care in Sanatorium schools shall be paid according to the contract

arrangements between health insurance and medical facilities in accordance

with the regulations on price control ^ 4).



§ 14



For healthcare provided within the framework of emergency care in

non-medical facilities, paid for by list of performances

the value of point determined in § 2.



§ 15



This Decree shall enter into force on 1 January 2000. January 1, 2008.



Minister: MUDr. Julínek, MBA in r.



Annex 1



The value of the item, the amount of the reimbursement of health care and regulatory restrictions pursuant to § 3



And institutional care) according to § 3 (2). 1



1. Reimbursement of medical equipment in 2008 includes individually

contractually agreed lump-sum payment and folder folder.



2. Individually contractually agreed payment folder includes remuneration for

health care covered according to the classification of hospitalized

patients ^ 5) (hereinafter referred to as "the classification") into groups related to diagnosis

08021, 08022, 08023, 08041, 08042, 08043, 08181, 08182 and 08183 (

"the listed group") set out in section 3.2 and remuneration for medicinal

medicines and foods for special medical purposes (hereinafter referred to as "medicinal

preparations ") paid in 2007 on the basis of a special contract with the

health insurance under another law ^ 6). Amount and method

the payment of this health care health insurance company contractually agreed with the

the medical establishment. If the medical health insurance

the device shall agree, individually contractually agreed the payment may

include payment of other health care, than is stated in the first sentence; in

this case, this remuneration included in the remuneration referred to in point 3.1.

(Uref or Lref).



2.1 health insurance in 2008, will provide all medical

In summary, the remuneration for the facilities provided by the health care included

According to the classification in the listed groups at least 104.8%

the reimbursement of such care in 2007. Contracted by the health insurance fund shall ensure

the provision of this health care at least the same number of insured persons, as in

in 2007, with the health insurance fund shall take into account the change in 2008

the number of its policy holders compared to 2007, also in the amount of the remuneration.



2.2 health insurance in 2008, will provide all medical

equipment in summary, remuneration for reimbursable medicinal products in 2007 on the

the basis of a special contract with a health insurance company, according to another legal


předpisu6), at least in the amount of reimbursement of such care 104.8% in 2007,

While health insurance in 2008, taking into account the change in the number of its

insured persons compared to 2007.



3. The flat-rate payment folder (PUV2008), lays down the procedure for the year 2008

referred to in points 3.1 to 3.11. The reference period is the year 2007.

A flat-rate component of the remuneration is based on a basic flat-rate remuneration, which

the calculation is shown in section 3.1.



3.1 Basic lump-sum payment (PUZ2008), which includes a fixed remuneration

for inpatient care (PUZhosp2008) and the flat-rate payment for outpatient

care (PUZamb2008), referred to in section 3.3, shall be as follows:



PUZ2008 = (PUref-Uref-Lref) Cn



where:



PUref total remuneration payable to a healthcare

equipment for care provided in the reference

the period to March 31, 2008 and declared health

insurance recognised in may, after the settlement of all

regulatory measures, with the exception of the regulation on the

prescribed medicines and medical

resources. The total payment is not included

health care, which is no longer for the year 2008

nasmlouvána



Uref total remuneration for health care medical

the equipment provided in the reference period, the area declared

to March 31, 2008, and the health insurance fund recognised until 31 March 2006. 5.

2008, included according to the classification in the listed

groups



The amount of the remuneration for the calculation of Uref PUZ2008 down

as follows:



Uref = Vref * ICBref + ZUMref + ZULPref + LPref + KPref



where:



Vref number of medical facility in the reference

the period declared and health insurance company

recognised for services performed during the

hospitalizations, which are according to the classification

included in the listed groups



ICBref calculated individual price point

medical equipment, which shall be fixed as

share U2007/B2007, where:



U2007 total remuneration payable

medical devices for all

healthcare provided in the reference

the period after the settlement of all regulatory

measures, with the exception of regulation on the prescribed

medicinal products and medical devices,

reduced reimbursement for separately charged to healing

preparations and posted material,

granted in the reference period, the reported

and health insurance company recognized in the context of

in patient care, a standard amount that you

are reimbursed medicinal products pursuant to § 17 para. 7

the law and the payment of other health

care paid in Czech Crowns (KPref)



Total number of times B2007 medical facilities

declared and recognized health insurance

points for health care provided

in the reference period



ZUMref the total amount of the reimbursement of medical

the device reported and health insurance company

recognised separately posted material provided

in the reference period in connection with the performances,

made during the hospitalizations, which are

According to the classification included in the listed

groups



ZULPref the total amount of the reimbursement of medical

the device reported and health insurance company

recognised separately charged to medicinal products

granted in the reference period in the context of

with the performances, that were made during the hospitalizations, which

are according to the classification included in the listed

groups



LPref flat-rate amount shall be paid to the healing

preparations for ošetřovacím days and reported

health insurance company recognised as reference

the time period to hospitalisations, which are

According to the classification included in the listed

groups



KPref other health care paid in dollars (in addition to the

ZUMref, ZULPref and LPref) declared and health

insurance company recognized, provided the medical

the equipment during the hospitalizations, which are

According to the classification included in the listed

groups



Lref total remuneration for medicinal products reimbursable

in 2007, on the basis of a special contract with health

insurance company under another law ^ 6)

the medical facility health insurance

granted in the reference period



CN ratio rise in flat-rate remuneration, which is for the year

2008 set at 1.048



3.2 the group related to the diagnosis according to the classification of these indices

groups (hereinafter referred to as "indexes"):

-------- --------------------------------------------------------------------------------- ------------

IR-DRG ^ 5) group name Index

-------- --------------------------------------------------------------------------------- ------------

00011 HEART TRANSPLANTS and/or LUNG without CC 23.0724

00012 HEART TRANSPLANTS and/or LUNG with CC 31.7291

00013 HEART TRANSPLANTS and/or LUNG with MCC 49.8110

00021 LIVER TRANSPLANTATION without CC 22.4577

00022 LIVER TRANSPLANTATION with CC 22.6268

00023 LIVER TRANSPLANT with MCC 38.2611

00031 BONE MARROW TRANSPLANTATION without CC 18.2677

00032 BONE MARROW TRANSPLANTATION with CC 19.1717

00033 BONE MARROW TRANSPLANT with MCC 23.5596

00041 LONG-TERM MECHANICAL VENTILATION with TRACHEOSTOMIÍ without-CC 10.3796

00042 LONG-TERM MECHANICAL VENTILATION with TRACHEOSTOMIÍ with CC to 16.5360

00043 LONG-TERM MECHANICAL VENTILATION with TRACHEOSTOMIÍ with MCC 16.5360

00051 LONG-TERM MECHANICAL VENTILATION without TRACHEOSTOMY, without CC 8.0537

00052 LONG TERM MECHANICAL VENTILATION without TRACHEOSTOMY with CC 8.0537

00053 LONG TERM MECHANICAL VENTILATION without TRACHEOSTOMY with MCC 12.2795

01011 CRANIOTOMY without CC 6.3645

01012 CRANIOTOMY with CC 8.5903

01013 CRANIOTOMY with MCC 13.4239

01021 SPINAL PERFORMANCES without CC 4.0736

01022 SPINAL PERFORMANCES with CC 8.8688

01023 SPINAL PERFORMANCES with MCC 11.2103

01031 EXTRACRANIAL ARTERIES PERFORMANCES without CC 2.4735

01032 PERFORMANCES on the EXTRACRANIAL ARTERIES with CC 2.4941

01033 PERFORMANCES on the EXTRACRANIAL ARTERIES with MCC 3.2675

01041 PERFORMANCES on the CRANIAL and peripheral NERVES without CC 0.4965

01042 PERFORMANCES on the CRANIAL and peripheral NERVES with CC 0.6858

01043 PERFORMANCES on the CRANIAL and peripheral NERVES with MCC 0.9640

01051 CARPAL TUNNEL RELEASE without CC 0.1705

01052 CARPAL TUNNEL RELEASE with CC 0.2192

01053 CARPAL TUNNEL RELEASE with MCC 0.2327

01061 OTHER PERFORMANCES in DISEASES and DISORDERS of the NERVOUS SYSTEM without CC 1.4935

OTHER PERFORMANCES in 01062 diseases and DISORDERS of the NERVOUS SYSTEM with CC 2.6640

01063 OTHER PERFORMANCES in DISEASES and DISORDERS of the NERVOUS SYSTEM with MCC 8.6239

01301 disorders and SPINAL CORD INJURIES without CC 0.7136

01302 disorders and SPINAL CORD INJURIES with CC 1.1500

01303 disorders and SPINAL CORD INJURIES with MCC 2.4426

01311 MALIGNANCIES, SOME INFECTIONS and degenerative DISORDERS NERVOVÉHOSYSTÉMU 0.8321

WITHOUT CC

01312 MALIGNANCIES, SOME INFECTIONS and degenerative DISORDERS of the NERVOVÉHOSYSTÉMU with 0.9123

CC

01313 MALIGNANCIES, SOME INFECTIONS and degenerative DISORDERS of the NERVOVÉHOSYSTÉMU with 1.3147

MCC

01321 MULTIPLE SCLEROSIS and CEREBELLAR ATAXIA without CC 0.4256

01322 MULTIPLE SCLEROSIS and CEREBELLAR ATAXIA with CC 0.6226

01323 MULTIPLE SCLEROSIS and CEREBELLAR ATAXIA with MCC 0.9848

01331 TRAUMATIC INTRACRANIAL BLEEDING without CC 1.2361

01332 TRAUMATIC INTRACRANIAL HEMORRHAGE with CC 1.5223

01333 TRAUMATIC INTRACRANIAL HEMORRHAGE with MCC 2.4762

01341 STROKE with myocardial FREE CC 0.9063

01342 STROKE with myocardial with CC 0.9904

01343 STROKE with myocardial with MCC 1.3997

01351 NON-SPECIFIC STROKE and PRECEREBRÁLNÍ OCCLUSION without MYOCARDIAL without CC 0.7514

01352 NON-SPECIFIC STROKE and PRECEREBRÁLNÍ OCCLUSION without MYOCARDIAL with CC 0.8282

01353 NON-SPECIFIC STROKE and PRECEREBRÁLNÍ OCCLUSION without MYOCARDIAL with MCC 1.0579

01361 TRANSIENT ISCHAEMIC ATTACK without CC 0.5569

01362 TRANSIENT ISCHEMIC ATTACK with CC 0.6117

01363 TRANSIENT ISCHEMIC ATTACK with MCC 0.6776

01371 CRANIAL and PERIPHERAL NERVES DISORDERS without CC 0.6457

01372 DISORDERS CRANIAL and PERIPHERAL NERVES with CC 0.7490

01373 DISORDERS CRANIAL and PERIPHERAL NERVES with MCC 0.8315

01381 bacterial and TUBERCULOSIS INFECTION of the NERVOUS SYSTEM without CC 2.4394

01382 bacterial and TUBERCULOSIS INFECTION of the NERVOUS SYSTEM with CC 3.4536

01383 bacterial and TUBERCULOSIS INFECTION of the NERVOUS SYSTEM with MCC 5.0796

01391 NEBAKTERIÁLNÍ INFECTION of the NERVOUS SYSTEM, in ADDITION to VIRAL MENINGITIS BEZCC 0.8985

01392 NEBAKTERIÁLNÍ INFECTION of the NERVOUS SYSTEM, in ADDITION to VIRAL MENINGITIS with CC 1.0381

01393 NEBAKTERIÁLNÍ INFECTION of the NERVOUS SYSTEM, in ADDITION to VIRAL MENINGITIS with MCC 2.4216

01401 VIRAL MENINGITIS without CC 1.2808

01402 VIRAL MENINGITIS with CC 1.4911

01403 VIRAL MENINGITIS with MCC 1.7434

01411 NETRAUMATICKÁ DISORDER of CONSCIOUSNESS and coma without CC 0.6490

01412 NETRAUMATICKÁ DISORDER of CONSCIOUSNESS and coma with CC 0.9169


01413 NETRAUMATICKÁ DISORDER of CONSCIOUSNESS and coma with MCC 2.0175

01421 EPILEPTIC SEIZURE without CC 0.4802

01422 EPILEPTIC SEIZURE with CC 0.6091

01423 EPILEPTIC SEIZURE with MCC 0.9097

01431 MIGRAINE and other HEADACHES without CC 0.5065

01432 MIGRAINE and other HEADACHES with CC 0.6458

01433 MIGRAINE and other HEADACHES with MCC 0.7611

01441 CRANIAL and intracranial INJURIES without CC 0.8406

01442 CRANIAL and intracranial injury with CC 1.2110

01443 CRANIAL and intracranial INJURIES with MCC 3.2695

01451 CONCUSSION without CC 0.2502

01452 CONCUSSION with CC 0.2904

01453 CONCUSSION with MCC 0.4669

01461 OTHER NERVOUS SYSTEM DISORDERS without CC 0.4765

01462 OTHER NERVOUS SYSTEM DISORDERS with CC 0.6615

01463 OTHER NERVOUS SYSTEM DISORDERS with MCC 1.0660

02011 ENUKLEACE, and PERFORMANCES on the EYECUP without CC 1.0556

02012 ENUKLEACE and PERFORMANCES on the EYECUP with CC 1.5662

02013 ENUKLEACE and PERFORMANCES on the EYECUP with MCC 1.5662

EXTRAOKULÁRNÍ in ADDITION to the performances, 02021 EYEPIECE without CC 0.3875

EXTRAOKULÁRNÍ in ADDITION to the performances, 02022 EYECUP with CC 0.5844

EXTRAOKULÁRNÍ in ADDITION to the performances, 02023 EYECUP with MCC 0.6275

02031 INTRAOCULAR LENSES, EXCEPT without the CC 0.7068

02032 INTRAOCULAR procedures, in ADDITION to LENSES with CC 0.8490

in ADDITION to the performances, 02033 INTRAOCULAR LENSES with MCC 0.9424

02041 PERFORMANCES on the LENS with or without VITREKTOMIE without-CC 0.5243

02042 the PERFORMANCES on the LENS with or without VITREKTOMIE with CC 0.5719

02043 PERFORMANCES on the LENS with or without VITREKTOMIE with the MCC 0.5719

02301 ACUTE and SERIOUS EYE INFECTION without CC 0.5036

02302 acute and SERIOUS EYE INFECTION with CC 0.5837

acute and SEVERE 02303 EYE INFECTION with MCC 1.3356

02311 NEUROLOGICAL and vascular EYE DISORDERS without CC 0.4753

02312 neurological and VASCULAR DISORDERS of the EYE with CC 0.6930

02313 NEUROLOGICAL and vascular EYE DISORDERS with MCC 0.8829

02321 OTHER EYE DISORDERS without CC 0.2992

02322 OTHER EYE DISORDERS with CC 0.3664

02323 OTHER EYE DISORDERS with MCC 0.4516

03011 GREAT PERFORMANCES on the larynx and TRACHEA without CC 3.6595

03012 GREAT PERFORMANCES on the larynx and TRACHEA with CC 6.6018

03013 GREAT PERFORMANCES on the larynx and TRACHEA with MCC 8.4143

03021 OTHER BIG PERFORMANCES on his head and neck without CC 3.0742

03022 OTHER BIG PERFORMANCES on the head and neck with CC 3.5674

OTHER LARGE 03023 PERFORMANCES on the head and neck with MCC 6.4343

03031 PERFORMANCES on the FACIAL bones, in ADDITION to LARGE POWER OUTPUTS on the HEAD and neck without CC 1.7449

03032 PERFORMANCES on the FACIAL bones, in ADDITION to LARGE POWER OUTPUTS on the HEAD and neck with CC 2.0582

03033 PERFORMANCES on the FACIAL bones, in ADDITION to LARGE POWER OUTPUTS on the HEAD and neck with MCC 4.4506

03041 PERFORMANCES on the MOUTH without CC 0.8561

03042 PERFORMANCES on mouth with CC 0.8561

03043 PERFORMANCES on mouth with MCC 1.0999

03051 PERFORMANCES on the CAVITIES and MASTOIDU without-CC 1.4393

03052 PERFORMANCES on the CAVITIES and MASTOIDU with CC to 1.4716

03053 PERFORMANCES on the CAVITIES and MASTOIDU with MCC 1.9900

03061 PERFORMANCES on SALIVARY GLAND without CC 1.0647

03062 PERFORMANCES on SALIVARY GLAND with CC 1.3239

PERFORMANCES on the SALIVARY GLAND 03063 with MCC 1.3773

03071 AXLE of cleft lip and PALATE without CC 1.7970

03072 AXLE of cleft lip and PALATE with CC 1.7970

03073 AXLE of cleft lip and PALATE with MCC 1.7970

03081 PERFORMANCES on the CERVICAL and nasal ALMONDS without CC 0.4975

03082 PERFORMANCES on the CERVICAL and nasal ALMONDS with CC 0.6572

03083 PERFORMANCES on the CERVICAL and nasal ALMONDS with MCC 1.0657

03091 OTHER PERFORMANCES in DISORDERS and DISEASES of ears, nose, mouth and throat without CC 0.7784

03092 OTHER PERFORMANCES with FAULTS and DISEASES of the ears, nose, mouth and throat with CC 0.8953

03093 OTHER PERFORMANCES in DISORDERS and DISEASES of ears, nose, mouth and throat with MCC 1.2975

03301 MALIGNANT DISEASE of ear, nose, mouth and throat without CC 0.8106

03302 MALIGNANT DISEASE of the ear, nose, mouth and throat with CC 0.8465

03303 MALIGNANT DISEASE ear, nose, mouth and throat with MCC 0.8465

03311 BALANCE DISORDERS without CC 0.5348

03312 BALANCE DISORDERS with CC 0.5892

03313 BALANCE DISORDERS with MCC 0.7135

without CC 0.3438 03321 EPISTAXIS

03322 EPISTAXIS with CC 0.4353

03323 EPISTAXIS with MCC 0.5223

03331 EPIGLOTTITIS, OTITIS MEDIA, infection of the upper respiratory tract, LARYNGOTRACHEITIS without 0.3300

CC

03332 EPIGLOTTITIS, OTITIS MEDIA, infection of the upper respiratory tract, LARYNGOTRACHEITIS with 0.4540

CC

03333 EPIGLOTTITIS, OTITIS MEDIA, infection of the upper respiratory tract, LARYNGOTRACHEITIS with 0.5898

MCC

DISEASES of the TEETH and mouth 03341 without CC 0.5060

03342 DISEASES of the TEETH and mouth with CC 0.5659

DISEASES of the TEETH and mouth 03343 with MCC 0.7616

03351 OTHER DISORDERS of the ears, nose, mouth and throat without CC 0.4165

03352 OTHER DISORDERS of the ears, nose, mouth and throat with CC 0.5351

OTHER DISORDERS 03353 ears, nose, mouth and throat with MCC 0.5427

04011 LARGE THORACIC PERFORMANCES without CC 4.8107

04012 LARGE THORACIC PERFORMANCES with CC 5.4528

04013 BIG CHEST with MCC 8.4785

04021 SMALLER CHEST PERFORMANCES without CC 3.2354

04022 SMALLER CHEST with CC 3.2354

04023 SMALLER CHEST with MCC 4.6582

04031 OTHER PERFORMANCES in DISORDERS and DISEASES of the RESPIRATORY SYSTEM without CC 1.6252

04032 OTHER PERFORMANCES in DISORDERS and DISEASES of the RESPIRATORY SYSTEM with CC 2.2363

04033 OTHER PERFORMANCES in DISORDERS and DISEASES of the RESPIRATORY SYSTEM with MCC 3.4523

04301 CYSTIC FIBROSIS without CC 2.4258

04302 CYSTIC FIBROSIS with CC 2.4258

04303 CYSTIC FIBROSIS with MCC 2.7644

04310 RESPIRATORY FAILURE 2.8649

04321 PULMONARY EMBOLISM without CC 1.1455

04322 PULMONARY EMBOLISM with CC 1.1961

04323 PULMONARY EMBOLISM with MCC 1.3398

04331 SEVERE TRAUMA to the CHEST without CC 0.5520

04332 SEVERE TRAUMA to CHEST with CC 0.8659

04333 SEVERE TRAUMA to CHEST with MCC 1.7009

04341 MALIGNANT DISEASE RESPIRATORY SYSTEM without CC 0.8615

04342 MALIGNANT DISEASE of the RESPIRATORY SYSTEM with CC 0.8615

04343 MALIGNANT DISEASE RESPIRATORY SYSTEM with MCC 1.1205

04351 RESPIRATORY SYSTEM infections and inflammations without CC 1.0908

04352 RESPIRATORY SYSTEM infections and inflammations with CC 1.1928

04353 RESPIRATORY SYSTEM infections and inflammations with MCC 2.3344

04361 SIMPLE pneumonia and WHOOPING COUGH without CC 0.7420

04362 SIMPLE pneumonia and WHOOPING COUGH with CC 0.9430

04363 SIMPLE pneumonia and WHOOPING COUGH with MCC 1.3050

04371 CHRONIC OBSTRUCTIVE PULMONARY DISEASE without CC 0.6663

04372 CHRONIC OBSTRUCTIVE PULMONARY disease with CC 0.7691

04373 CHRONIC OBSTRUCTIVE PULMONARY disease with MCC 1.0133

asthma and BRONCHIOLITIS 04381 without CC 0.4676

04382 asthma and BRONCHIOLITIS with CC 0.6338

04383 asthma and BRONCHIOLITIS with MCC 0.8267

04391 INTERSTITIAL LUNG DISEASE without CC 1.0433

04392 INTERSTITIAL LUNG DISEASE with CC 1.0974

04393 INTERSTITIAL LUNG DISEASE with MCC 1.6177

04401 PNEUMOTHORAX without CC PLEURÁNÍ the EFFUSION and 1.0550

04402 PNEUMOTHORAX and PLEURÁNÍ EFFUSION with CC 1.2511

04403 PNEUMOTHORAX and PLEURÁNÍ EFFUSION with MCC 1.7318

04411 signs, symptoms and other RESPIRATORY SYSTEM DIAGNOSIS without CC 0.4874

04412 signs, symptoms and other RESPIRATORY SYSTEM DIAGNOSIS with CC 0.6806

04413 signs, symptoms and other RESPIRATORY SYSTEM DIAGNOSIS with MCC 0.8956

05011 CARDIAC DEFIBRILLATOR IMPLANT and to SUPPORT HEART FUNCTION without CC 52.5905

05012 CARDIAC DEFIBRILLATOR IMPLANT and to SUPPORT HEART FUNCTION with CC 54.0460

05013 CARDIAC DEFIBRILLATOR IMPLANT and to SUPPORT HEART FUNCTION with MCC 56.6298

05021 PERFORMANCES on the HEART with the HEART-CATH LAB FLAP without CC 16.7875

05022 PERFORMANCES on the HEART with the HEART-CATH LAB FLAP with CC 22.0351

05023 PERFORMANCES on the HEART with the HEART-CATH LAB FLAP with MCC 22.2832

the operations and PROCEDURES for 05031 CONGENITAL HEART DEFECTS without CC 10.1476

05032 operations and PROCEDURES for CONGENITAL HEART DISEASE with CC 11.1589

05033 operations and PROCEDURES for CONGENITAL HEART DEFECTS with MCC 18.1966

05041 PERFORMANCES on HEART FLAP without CARDIAC CATHETERIZATION without CC 14.5375

05042 PERFORMANCES on HEART FLAP without CARDIAC CATHETERIZATION with CC 16.3142

05043 PERFORMANCES on HEART FLAP without cardiac catheterization with MCC 18.6424

05051 CORONARY BYPASS SURGERY with HEART-CATH LAB without CC 12.0895

05052 CORONARY BYPASS SURGERY with HEART-CATH LAB with CC 14.0417

05053 CORONARY BYPASS SURGERY with HEART-CATH LAB with MCC 15.0073

05061 CORONARY BYPASS SURGERY without CARDIAC CATHETERIZATION without CC 10.0195

05062 CORONARY BYPASS SURGERY without CARDIAC CATHETERIZATION with CC 10.4284

05063 CORONARY BYPASS SURGERY without cardiac catheterization with MCC 12.5552

PERMANENT PACEMAKER IMPLANTATION in 05070 acute myocardial infarction, 11.9405 FAILURE

HEART OR SHOCK

OTHER PERFORMANCES of the CARDIOTHORACIC 05081 without CC 5.9993

05082 OTHER CARDIOTHORACIC PERFORMANCES with CC 5.9993

05083 OTHER CARDIOTHORACIC PERFORMANCES with MCC 5.9993

05091 LARGE ABDOMINAL VASCULAR PERFORMANCE without CC 6.6534

05092 LARGE ABDOMINAL VASCULAR PERFORMANCE with CC 8.1396

05093 LARGE ABDOMINAL VASCULAR PERFORMANCE with MCC 9.5806

05101 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE with ACUTE MYOCARDIAL INFARCTION without CC 6.9680

05102 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE with ACUTE MYOCARDIAL INFARCTION with CC 7.0606


05103 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE with acute MYOCARDIAL INFARCTION with MCC 8.0973

IMPLANTATION of PERMANENT PACEMAKER 05111 without acute myocardial infarction, 6.5566 FAILURE

HEART OR SHOCK WITHOUT CC

IMPLANTATION of PERMANENT PACEMAKER 05112 without acute myocardial infarction, 6.5566 FAILURE

HEART OR SHOCK WITH CC

IMPLANTATION of PERMANENT PACEMAKER 05113 without acute myocardial infarction, 7.2851 FAILURE

HEART OR SHOCK WITH MCC

LARGE THORACIC VASCULAR 05121 PERFORMANCES without CC 6.5536

LARGE THORACIC VASCULAR 05122 PERFORMANCES with CC 6.5536

05123 LARGE THORACIC VASCULAR PERFORMANCE with MCC 10.3806

05131 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE MYOCARDIAL INFARCTION BEZCC 5.7124

05132 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE MYOCARDIAL INFARCTION with CC 5.8581

05133 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE MYOCARDIAL INFARCTION with MCC 6.4009

OTHER VASCULAR 05141 PERFORMANCES without CC 4.3372

OTHER VASCULAR 05142 PERFORMANCES with CC 4.4854

OTHER VASCULAR 05143 PERFORMANCES with MCC 6.3226

05151 AMPUTATION DUE to a FAILURE of the CIRCULATORY SYSTEM, in ADDITION to the UPPER LIMBS and fingers at the foot of 2.3171

WITHOUT CC

05152 AMPUTATION DUE to a FAILURE of the CIRCULATORY SYSTEM, in ADDITION to the UPPER LIMBS and fingers at the foot with 2.7170

CC

05153 AMPUTATION DUE to a FAILURE of the CIRCULATORY SYSTEM, in ADDITION to the UPPER LIMBS and fingers at the foot with 3.3721

MCC

pacemaker and DEFIBRILLATOR 05161 REPLACEMENT without CC 4.7336

pacemaker and DEFIBRILLATOR REPLACEMENT 05162 with CC 4.7336

pacemaker and DEFIBRILLATOR 05163 REPLACEMENT with MCC 6.3416

05171 AMPUTATION of UPPER LIMB and TOE on leg DUE to a FAULT of the CIRCULATORY SYSTÉMUBEZ CC 1.3688

05172 AMPUTATION of UPPER LIMB and TOE on leg DUE to a FAULT of the CIRCULATORY SYSTÉMUS CC 1.9549

05173 AMPUTATION of UPPER LIMB and TOE on leg DUE to a FAULT of the CIRCULATORY SYSTÉMUS MCC 2.9111

CONTROL pacemaker and DEFIBRILLATOR 05181, EXCEPT for REPLACEMENT of EQUIPMENT BEZCC 1.0108

CONTROL pacemaker and DEFIBRILLATOR 05182, EXCEPT for REPLACEMENT of EQUIPMENT with CC 1.6628

CONTROL pacemaker and DEFIBRILLATOR 05183, EXCEPT for REPLACEMENT of equipment with MCC 1.6628

05191 LIGATURE and STRIPPING the VESSELS without CC 0.6642

05192 LIGATURE and STRIPPING the VESSELS with CC 0.7653

05193 LIGATURE and STRIPPING the VESSELS with MCC 0.7653

05201 OTHER PERFORMANCES in DISEASES and DISORDERS of the CIRCULATORY SYSTEM without CC 1.5421

05202 OTHER PERFORMANCES in DISEASES and DISORDERS of the CIRCULATORY SYSTEM with CC 2.2460

05203 OTHER PERFORMANCES in DISEASES and DISORDERS of the CIRCULATORY SYSTEM with MCC 5.6663

05301 CARDIAC CATHETERIZATION DURING ACUTE MYOCARDIAL INFARCTION without CC 1.6476

05302 CARDIAC CATHETERIZATION in ACUTE MYOCARDIAL INFARCTION with CC 1.7366

05303 CARDIAC CATHETERIZATION in ACUTE MYOCARDIAL INFARCTION with MCC 2.3639

05311 CARDIAC CATHETERIZATION in the ISCHEMIC HEART without CC 1.0102

05312 CARDIAC CATHETERIZATION in the ISCHEMIC HEART with CC 1.1061

05313 CARDIAC CATHETERIZATION in the ISCHEMIC HEART with MCC 1.2632

05321 CARDIAC CATHETERIZATION when OTHER CIRCULATORY SYSTEM DISORDERS without CC 1.4642

05322 CARDIAC CATHETERIZATION when OTHER DISORDERS of the CIRCULATORY SYSTEM with CC 1.7087

05323 CARDIAC CATHETERIZATION when OTHER DISORDERS of the CIRCULATORY SYSTEM with MCC 2.6629

05331 ACUTE MYOCARDIAL INFARCTION without CC 0.6724

05332 ACUTE MYOCARDIAL INFARCTION with CC 0.9479

05333 ACUTE MYOCARDIAL INFARCTION with MCC 1.2698

05341 acute and subacute ENDOCARDITIS without CC 2.4260

acute and subacute ENDOCARDITIS 05342 with CC 2.5894

acute and subacute ENDOCARDITIS 05343 with MCC 8.4743

05351 HEART FAILURE without CC 0.7410

05352 HEART FAILURE with CC 0.8282

05353 HEART FAILURE with MCC 1.1121

05361 DEEP VEIN THROMBOSIS without CC 0.6206

05362 DEEP VENOUS THROMBOSIS with CC 0.7194

05363 DEEP VENOUS THROMBOSIS with MCC 0.8818

05371 UNEXPLAINED CARDIAC ARREST without CC 1.0161

05372 UNEXPLAINED CARDIAC ARREST with CC 1.0161

05373 UNEXPLAINED CARDIAC ARREST with MCC 2.1377

05381 PERIPHERAL and other vascular disorders without CC 0.7406

05382 PERIPHERAL and other vascular disorders with CC 0.8750

05383 PERIPHERAL and other vascular disorders with MCC 0.9188

05391 ATHEROSCLEROSIS without CC 0.5251

05392 ATHEROSCLEROSIS with CC 0.6371

05393 ATHEROSCLEROSIS with MCC 0.8796

05401 HYPERTENSION without CC 0.4471

05402 HYPERTENSION with CC 0.5140

05403 HYPERTENSION with MCC 0.6123

05411 VALVULAR and CONGENITAL HEART DISORDERS without CC 0.5000

05412 VALVULAR and CONGENITAL HEART DISORDERS with CC 0.7038

05413 CONGENITAL HEART and VALVULAR DISORDERS with MCC 1.1392

05421 CARDIAC ARRHYTHMIAS and CONDUCTION DISORDERS without CC 0.4945

05422 CARDIAC ARRHYTHMIA and CONDUCTION DISORDERS with CC 0.6543

05423 CARDIAC ARRHYTHMIAS and CONDUCTION DISORDERS with MCC 0.9152

05431 ANGINA and chest pain without CC 0.4569

05432 ANGINA and chest pain with CC 0.5615

05433 ANGINA and chest pain with MCC 0.7229

05441 syncope and COLLAPSE without CC 0.3978

05442 syncope and COLLAPSE with CC 0.5342

05443 syncope and COLLAPSE with MCC 0.6674

05451 CARDIOMYOPATHY without CC 0.4672

05452 CARDIOMYOPATHY with CC 0.6910

05453 CARDIOMYOPATHY with MCC 0.9185

05461 failures, reactions and complications of HEART or VASCULAR DEVICE 0.5407

OR PERFORMANCE WITHOUT CC

05462 failures, reactions and complications of HEART or VASCULAR INSTRUMENTS or PERFORMANCE with CC 0.6021

05463 failures, reactions and complications of HEART or VASCULAR INSTRUMENTS or PERFORMANCE with MCC 0.6021

OTHER DISORDERS of the CIRCULATORY SYSTEM 05471 without CC 0.5678

OTHER DISORDERS of the CIRCULATORY SYSTEM 05472 with CC 0.7468

OTHER DISORDERS of the CIRCULATORY SYSTEM 05473 with MCC 1.0016

06011 BIG PERFORMANCES on the THICK and THIN INTESTINE without CC 3.6731

GREAT PERFORMANCES on the THICK 06012 and THIN INTESTINE with CC 4.2191

06013 BIG PERFORMANCES on the THICK and THIN INTESTINE with MCC 5.6110

06021 BIG PERFORMANCES on the stomach, ESOPHAGUS and duodenum without CC 3.6624

06022 GREAT PERFORMANCES on the STOMACH, esophageal and duodenal ulcers with CC 4.8275

06023 BIG PERFORMANCES on the STOMACH, esophageal and duodenal ulcers with MCC 6.7506

06031 LESS PERFORMANCES on the THICK and THIN INTESTINE without CC 1.7879

06032 LESS PERFORMANCES on the THICK and THIN INTESTINE with CC 2.5501

06033 LESS PERFORMANCES on the THICK and THIN INTESTINE with MCC 3.4926

06041 RELEASE of TISSUE of PERITONEUM without CC 1.3429

06042 RELEASE of TISSUE of PERITONEUM with CC 1.6255

06043 RELEASE of TISSUE of PERITONEUM with MCC 2.0839

06051 PERFORMANCES on APENDIXU without-CC 1.0370

06052 PERFORMANCES at APENDIXU with CC to 1.2758

06053 PERFORMANCES on APENDIXU with MCC 1.8180

06061 LAPAROSCOPIC INGUINAL, femoral PERFORMANCE, UMBILICAL or EPIGASTRIC HERNIA 1.5392

WITHOUT CC

06062 LAPAROSCOPIC INGUINAL, femoral PERFORMANCE, UMBILICAL or EPIGASTRIC HERNIA 1.6371

WITH CC

06063 LAPAROSCOPIC INGUINAL, femoral PERFORMANCE, UMBILICAL or EPIGASTRIC HERNIA 1.7226

WITH MCC

06071 LESS PERFORMANCES on the stomach, ESOPHAGUS and duodenum without CC 3.0442

06072 LESS PERFORMANCES on the STOMACH, esophageal and duodenal ulcers with CC 3.3392

06073 LESS PERFORMANCES on the STOMACH, esophageal and duodenal ulcers with MCC 4.2782

LAPAROTOMICKÉ PERFORMANCE 06081 INGUINAL, Femoral, UMBILICAL or EPIGASTRIC HERNIA 0.7236

WITHOUT CC

LAPAROTOMICKÉ PERFORMANCE 06082 INGUINAL, Femoral, UMBILICAL or EPIGASTRIC HERNIA 1.0194

WITH CC

LAPAROTOMICKÉ PERFORMANCE 06083 INGUINAL, Femoral, UMBILICAL or EPIGASTRIC HERNIA 1.3567

WITH MCC

06091 anal and OSTOMY PERFORMANCES without CC 0.6235

06092 anal and OSTOMY PERFORMANCES with CC 0.7519

06093 anal and OSTOMY PERFORMANCES with MCC 0.8770

06101 OTHER PERFORMANCES in DISORDERS and DISEASES of the DIGESTIVE SYSTEM without CC 1.0202

06102 OTHER PERFORMANCES in DISORDERS and DISEASES of the DIGESTIVE SYSTEM with CC 2.1232

06103 OTHER PERFORMANCES in DISORDERS and DISEASES of the DIGESTIVE SYSTEM with MCC 3.0604

06111 PERFORMANCES on APENDIXU when the MAIN COMPLICATING DIAGNOSIS without CC 1.4644

06112 PERFORMANCES on APENDIXU when the MAIN COMPLICATING DIAGNOSIS with CC 1.8829

06113 PERFORMANCES on APENDIXU when COMPLICATING the MAIN DIAGNOSIS with MCC 2.5313

MALIGNANT DISEASES of the DIGESTIVE SYSTEM 06301 without CC 0.5194

MALIGNANT DISEASES of the DIGESTIVE SYSTEM 06302 with CC 0.5713

06303 MALIGNANT DISEASE of the DIGESTIVE SYSTEM with MCC 0.9041

06311 peptic ulcer and GASTRITIS without CC 0.4338

06312 peptic ulcer and GASTRITIS with CC 0.7049

06313 peptic ulcer and GASTRITIS with MCC 0.9936

06321 ESOPHAGEAL DISORDERS without CC 0.4639

06322 ESOPHAGEAL DISORDERS with CC 0.6652

06323 ESOPHAGEAL DISORDERS with MCC 0.9543

06331 DIVERTICULITIS, DIVERTICULOSIS and INFLAMMATORY DISEASES of the INTESTINE without CC 0.5172

06332 DIVERTICULITIS, DIVERTICULOSIS and INFLAMMATORY DISEASE of the BOWEL with CC 0.6618

06333 diverticulosis and diverticulitis, an INFLAMMATORY DISEASE of the intestines with MCC 1.0051

06341 VASCULAR INSUFFICIENCY, GASTROINTESTINAL SYSTEM without CC 0.2081

06342 VASCULAR INSUFFICIENCY, GASTROINTESTINAL SYSTEM with CC 0.2849

06343 VASCULAR INSUFFICIENCY, GASTROINTESTINAL SYSTEM with MCC 1.7401

06351 OBSTRUCTION of the GASTROINTESTINAL SYSTEM without CC 0.4627

OBSTRUCTION of the GASTROINTESTINAL SYSTEM 06352 with CC 0.6720


06353 OBSTRUCTION of the GASTROINTESTINAL SYSTEM with MCC 0.9796

SERIOUS INFECTIONS of the GASTROINTESTINAL SYSTEM 06361 without CC 0.9576

SERIOUS INFECTIONS of the GASTROINTESTINAL SYSTEM 06362 with CC 1.3744

SERIOUS INFECTIONS of the GASTROINTESTINAL SYSTEM 06363 with MCC 3.4782

06371 OTHER GASTROENTERITIS and ABDOMINAL PAIN without CC 0.2976

06372 OTHER GASTROENTERITIS and ABDOMINAL PAIN with CC 0.4062

06373 OTHER GASTROENTERITIS and ABDOMINAL PAIN with MCC 0.5476

OTHER DISORDERS of the DIGESTIVE SYSTEM 06381 without CC 0.3462

06382 OTHER DISORDERS of the DIGESTIVE SYSTEM with CC 0.5037

06383 OTHER DISORDERS of the DIGESTIVE SYSTEM with MCC 0.7064

07011 PERFORMANCES on the pancreas, the liver and the CLUTCH without CC 5.0070

07012 PERFORMANCES on the pancreas, the liver and the clutch-CC 6.4394

07013 PERFORMANCES on the pancreas, LIVER and couplings with MCC 9.8310

07021 GREAT PERFORMANCES on the BILIARY TRACT without CC 3.5489

07022 GREAT PERFORMANCES on the BILIARY TRACT with CC 3.9966

07023 GREAT PERFORMANCES on the BILIARY TRACT with MCC 5.3700

in ADDITION to LAPAROSCOPIC cholecystectomy 07031 without CC 1.6134

in ADDITION to LAPAROSCOPIC cholecystectomy 07032 with CC 2.1594

in ADDITION to LAPAROSCOPIC cholecystectomy 07033 with MCC 2.9560

07041 LAPAROSCOPIC CHOLECYSTECTOMY without CC 1.6302

07042 LAPAROSCOPIC CHOLECYSTECTOMY with CC 1.8555

07043 LAPAROSCOPIC CHOLECYSTECTOMY with MCC 2.2424

07051 OTHER PERFORMANCES in DISORDERS and DISEASES of HEPATOBILIÁRNÍHO system and PANCREATIC 2.3623

WITHOUT CC

07052 OTHER PERFORMANCES in DISORDERS and DISEASES of the PANCREAS with HEPATOBILIÁRNÍHO system and 3.2639

CC

07053 OTHER PERFORMANCES in DISORDERS and DISEASES of the PANCREAS with HEPATOBILIÁRNÍHO system and 6.9960

MCC

CIRRHOSIS and ALCOHOLIC HEPATITIS 07301 without CC 0.6742

07302 CIRRHOSIS and ALCOHOLIC HEPATITIS with CC 0.8163

07303 CIRRHOSIS and ALCOHOLIC HEPATITIS with MCC 1.1692

07311 MALIGNANCIES HEPATOBILIÁRNÍHO SYSTEM and pancreas without CC 0.7157

07312 HEPATOBILIÁRNÍHO system and MALIGNANT DISEASE of the PANCREAS with CC 0.7541

07313 MALIGNANCIES HEPATOBILIÁRNÍHO SYSTEM and pancreas with MCC 1.0596

07321 PANCREATIC DISORDERS, in ADDITION to the MALIGNANT DISEASE without CC 0.7580

07322 PANCREATIC DISORDERS, in ADDITION to the MALIGNANT DISEASE with CC 1.0448

07323 PANCREATIC DISORDERS, in ADDITION to the MALIGNANT DISEASE with MCC 1.7183

07331 liver disorders, in ADDITION to CIRRHOSIS and alcoholic HEPATITIS, MALIGNANT NON-CC 0.5102

07332 liver disorders, in ADDITION to CIRRHOSIS and alcoholic HEPATITIS, MALIGNANT with CC 0.7458

07333 liver disorders, in ADDITION to CIRRHOSIS and alcoholic HEPATITIS, MALIGNANT with MCC 1.0898

OTHER DISORDERS of the BILIARY TRACT 07341 without CC 0.5747

OTHER DISORDERS of the BILIARY TRACT 07342 with CC 0.8173

07343 OTHER DISORDERS of the BILE DUCTS with MCC 1.1038

the FUSION of the SPINE when 08011 DEFORMITÁCH and SCOLIOSIS without CC 11.5900

the FUSION of the SPINE when 08012 DEFORMITÁCH and SCOLIOSIS with CC 11.5900

the FUSION of the SPINE when 08013 DEFORMITÁCH and SCOLIOSIS with MCC 11.5900

08021 BILATERAL and multiple GREAT PERFORMANCES on the JOINTS of the LOWER LIMBS without CC 6.1211

08022 BILATERAL and multiple GREAT PERFORMANCES on the JOINTS of the LOWER LIMBS SCC 7.2069

08023 BILATERAL and multiple GREAT PERFORMANCES on the JOINTS of the LOWER LIMBS SMCC 12.2256

SPINAL FUSION 08031, not for the DEFORMITY without CC 6.9862

08032 FUSION spine, NOT for DEFORMITY with CC 8.7586

08033 FUSION of the SPINE, not for DEFORMITY with MCC 10.5248

08041 PERFORM REPLANTACE of the LOWER LIMBS and the JOINTS without CC 4.4515

08042 PERFORM REPLANTACE of the LOWER LIMBS and joints with CC 4.4617

08043 PERFORM REPLANTACE of the LOWER LIMBS and joints with MCC 5.0558

08051 RECONSTRUCTION PERFORMANCE of CRANIAL and FACIAL BONES without CC 2.9472

08052 RECONSTRUCTION PERFORMANCE of CRANIAL and FACIAL BONES with CC 2.9472

08053 RECONSTRUCTION PERFORMANCE of CRANIAL and FACIAL BONES with MCC 8.2626

08061 BIG PERFORMANCES REPLANTACE the UPPER LIMBS and the JOINTS without CC 3.3633

08062 BIG PERFORMANCES REPLANTACE the UPPER LIMBS and the joints with CC 5.1291

08063 PERFORM REPLANTACE of the UPPER EXTREMITIES and joints with MCC 9.9228

08071 AMPUTATION in MUSCULO-SKELETAL DISORDERS, and CONNECTIVE TISSUE DISORDERS without CC 2.7203

08072 AMPUTATION in MUSCULO-SKELETAL DISORDERS, connective tissue and the SCC 2.7203

08073 AMPUTATION in MUSCULO-SKELETAL DISORDERS, connective tissue and SMCC 4.9478

08081 PERFORMANCES on the HIPS and thigh BONES, in ADDITION to the LARGE JOINTS without CC REPLANTACE 2.6233

08082 PERFORMANCES on the HIPS and thigh BONES, in ADDITION to the REPLANTACE of LARGE JOINTS SCC 3.1903

08083 PERFORMANCES on the HIPS and thigh BONES, in ADDITION to the LARGE JOINTS SMCC REPLANTACE 3.9092

08091 SKIN GRAFTING or TISSUE for MUSCULOSKELETAL DISORDERS SYSTÉMUNEBO 0.6543

CONNECTIVE TISSUE IN ADDITION TO HAND WITHOUT CC

08092 SKIN GRAFTING or TISSUE for MUSCULOSKELETAL DISORDERS SYSTÉMUNEBO 1.1209

CONNECTIVE TISSUE IN ADDITION TO HAND WITH CC

08093 SKIN GRAFTING or TISSUE for MUSCULOSKELETAL DISORDERS SYSTÉMUNEBO 2.0521

CONNECTIVE TISSUE IN ADDITION TO HAND WITH MCC

08101 PERFORMANCES on the back and neck, in ADDITION to the FUSION of the SPINE without CC 2.0461

08102 PERFORMANCES on the back and neck, in ADDITION to the FUSION of the SPINE with CC 2.7290

08103 PERFORMANCES on the back and neck, in ADDITION to the FUSION of the SPINE with MCC 3.6808

08111 PERFORMANCES on the LOWER LEG and knee, HOCK, in ADDITION to the FOOT without CC 1.4430

08112 PERFORMANCES on the LOWER LEG and knee, HOCK, in addition to the FOOT with CC 1.8277

08113 PERFORMANCES on the LOWER LEG and knee, HOCK, in addition to the FOOT with MCC 2.3975

08121 REMOVAL of the INTERNAL FIXATION DEVICES without CC 0.4701

REMOVAL of INTERNAL FIXATION DEVICES 08122 with CC 0.5074

REMOVAL of INTERNAL FIXATION DEVICES 08123 with MCC 0.6439

08131 LOCAL RESECTION on the MUSCULOSKELETAL SYSTEM without CC 0.8485

08132 LOCAL RESECTION on the MUSCULOSKELETAL SYSTEM with CC 1.1269

08133 LOCAL RESECTION on the MUSCULOSKELETAL system with MCC 2.0512

08141 PERFORMANCES on FOOT without CC 0.5973

08142 PERFORMANCES on FOOT with CC 0.6442

08143 PERFORMANCES on FOOT with MCC 0.6442

08151 PERFORMANCES on the UPPER LIMBS without CC 0.8746

08152 PERFORMANCES on the UPPER EXTREMITIES with CC 1.2338

08153 PERFORMANCES on the UPPER EXTREMITY with MCC 1.8023

08161 PERFORMANCES on SOFT TISSUE without CC 0.6578

08162 PERFORMANCES on SOFT TISSUE with CC 0.8631

08163 PERFORMANCE on SOFT TISSUE with MCC 1.4940

the PERFORMANCES of the OTHER DISORDERS 08171 and DISEASES of the MUSCULOSKELETAL system and CONNECTIVE 0.9187

TISSUE WITHOUT CC

08172 OTHER PERFORMANCES in DISORDERS and DISEASES of the MUSCULOSKELETAL system and CONNECTIVE 1.2544

TISSUE WITH CC

08173 OTHER PERFORMANCES in DISORDERS and DISEASES of the MUSCULOSKELETAL system and CONNECTIVE 2.3116

TISSUE WITH MCC

08181 GREAT PERFORMANCES on the KNEE JOINT without CC 5.8446

08182 GREAT PERFORMANCES on the KNEE JOINT with CC 5.8446

08183 BIG PERFORMANCE on the KNEE JOINT with MCC 6.2074

08191 ARTHROSCOPY without CC 0.7043

08192 ARTHROSCOPY with CC 0.7188

08193 ARTHROSCOPY with MCC 0.8781

08301 FRACTURES of the FEMUR without CC 0.6936

08302 FRACTURES of the FEMUR with CC 0.8794

08303 FRACTURES of the FEMUR with MCC 1.0071

08311 FRACTURE DISLOCATION of the HIP, pelvis, or without CC 0.6422

08312 FRACTURE DISLOCATION of the HIP, pelvis, or with CC 0.7791

08313 FRACTURE DISLOCATION of the HIP, pelvis, or with MCC 0.8492

08321 FRACTURE or DISLOCATION, in ADDITION to the FEMUR and pelvis without CC 0.3808

08322 FRACTURE or DISLOCATION, in ADDITION to the FEMUR and pelvis with CC 0.5381

08323 FRACTURE or DISLOCATION, in ADDITION to the FEMUR and pelvis with MCC 0.7977

08331 MALIGNANT DISEASE MUSCULOSKELETAL and CONNECTIVE TISSUE DISORDERS, pathological 0.7854

FRACTURES WITHOUT CC

08332 MALIGNANT DISEASE MUSCULOSKELETAL and CONNECTIVE TISSUE DISORDERS, pathological 0.8351

FRACTURES WITH CC

08333 MALIGNANT DISEASE of the MUSCULOSKELETAL system and CONNECTIVE TISSUE, pathological 1.5143

FRACTURES WITH MCC

08341 OSTEOMYELITIS without CC 0.8291

08342 OSTEOMYELITIS with CC 0.8291

08343 OSTEOMYELITIS with MCC 1.4735

08351 SEPTIC ARTHRITIS without CC 0.8493

08352 SEPTIC ARTHRITIS with CC 1.4638

08353 SEPTIC ARTHRITIS with MCC 3.1266

CONNECTIVE TISSUE DISORDERS without 08361 CC 0.8386

08362 DISORDERS of CONNECTIVE TISSUE with CC 0.9048

08363 CONNECTIVE TISSUE DISORDERS with MCC 1.4629

08371 CONSERVATIVE TREATMENT of BACK PROBLEMS without CC 0.5933

08372 CONSERVATIVE TREATMENT of BACK PROBLEMS with CC 0.6885

08373 CONSERVATIVE TREATMENT of BACK PROBLEMS with MCC 0.7602

08381 OTHER DISEASES of bones and joints without CC 0.6199

08382 OTHER DISEASES of bones and joints with CC 0.7428

08383 OTHER DISEASES of bones and joints with MCC 0.8550

08391 failures, reactions and complications ORTHOPAEDIC APPARATUS or PERFORMANCE without CC 0.7127

08392 failures, reactions and complications ORTHOPAEDIC APPARATUS or PERFORMANCE with CC 1.0408

08393 failures, reactions and complications ORTHOPAEDIC APPARATUS or performance with MCC 1.1545

08401 MUSCULOSKELETAL SYMPTOMS, symptoms, sprains and MINOR INFLAMMATORY DISEASE 0.4304

WITHOUT CC

08402 MUSCULOSKELETAL SYMPTOMS, symptoms, sprains and MINOR INFLAMMATORY diseases with 0.5987

CC


08403 MUSCULOSKELETAL SYMPTOMS, symptoms, sprains and MINOR INFLAMMATORY diseases with 0.9768

MCC

08411 OTHER MUSCULO-SKELETAL DISORDERS, and CONNECTIVE TISSUE DISORDERS without CC 0.4172

08412 OTHER MUSCULO-SKELETAL DISORDERS, and CONNECTIVE TISSUE DISORDERS with CC 0.5994

08413 OTHER MUSCULO-SKELETAL DISORDERS, and CONNECTIVE TISSUE DISORDERS with MCC 0.8202

09011 SKIN GRAFT and/or DEBRIDEMENT without CC 0.8104

09012 SKIN GRAFT and/or DEBRIDEMENT with CC 1.3868

09013 SKIN GRAFT and/or DEBRIDEMENT with MCC 2.6426

09021 PERFORMANCES on the BREASTS without CC 0.8715

09022 PERFORMANCES on the BREASTS with CC 1.0977

09023 PERFORMANCES on the BREASTS with MCC 1.5319

the PERFORMANCES of the OTHER DISORDERS 09031 and DISEASES of the skin, subcutaneous tissue and BREAST without CC 0.4914

the PERFORMANCES of the OTHER DISORDERS 09032 and DISEASES of the skin, subcutaneous tissue and BREAST with CC 0.8577

09033 OTHER PERFORMANCES in DISORDERS and DISEASES of the skin, subcutaneous tissue and BREAST with MCC 1.2532

09301 SERIOUS SKIN DISORDERS without CC 0.7910

09302 SERIOUS SKIN DISORDERS with CC 0.9569

09303 SERIOUS SKIN DISORDERS with MCC 1.0804

MALIGNANT BREAST DISEASE without 09311 CC 0.7240

MALIGNANT BREAST DISEASE 09312 with CC 0.7240

MALIGNANT BREAST DISEASE 09313 with MCC 0.8668

09321 FLEGMÓNA without CC 0.5599

09322 FLEGMÓNA with CC to 0.7935

09323 FLEGMÓNA with MCC 0.9861

09331 INJURY to the skin, subcutaneous tissue and BREAST without CC 0.2672

09332 INJURY to the skin, subcutaneous tissue and BREAST with CC 0.3840

09333 INJURIES of the SKIN, subcutaneous tissue and BREAST with MCC 0.5430

09341 OTHER SKIN DISORDERS and breast disorders without CC 0.4746

09342 OTHER SKIN DISORDERS and BREAST DISORDERS with CC 0.6629

09343 OTHER BREAST disorders with MCC 0.7684

10011 PERFORMANCES on the ADRENAL GLANDS and the PITUITARY without CC 4.1931

10012 PERFORMANCES on the ADRENAL GLANDS, and PITUITARY GLAND with CC 4.8121

10013 PERFORMANCES on the ADRENAL GLANDS, and PITUITARY GLAND with MCC 6.0017

10021 SKIN GRAFT and DEBRIDEMENT of the WOUND when the ENDOCRINE, nutritional and metabolic 1.1880

DISORDERS WITHOUT CC

10022 SKIN GRAFT and DEBRIDEMENT of the WOUND when the ENDOCRINE, nutritional and metabolic 2.9672

DISORDERS WITH CC

10023 a SKIN GRAFT and DEBRIDEMENT of the WOUND when the ENDOCRINE, nutritional and metabolic 3.6079

DISORDERS WITH MCC

10031 PERFORMANCES for OBESITY without CC 3.3479

10032 PERFORMANCES for OBESITY with CC 4.0525

10033 PERFORMANCES for OBESITY with MCC 10.0677

10041 AMPUTATION of the LOWER LIMB in ENDOCRINE, nutritional, and METABOLICKÝCHPORUCHÁCH 1.9357

WITHOUT CC

10042 AMPUTATION of the LOWER LIMB in ENDOCRINE, nutritional, and METABOLICKÝCHPORUCHÁCH 2.7020

WITH CC

10043 AMPUTATION of the LOWER LIMB in ENDOCRINE, nutritional, and METABOLICKÝCHPORUCHÁCH 2.7020

WITH MCC

10051 PERFORMANCES on the THYROID and PŘÍŠTITNÉ GLAND, THYROGLOSSÁLNÍ PERFORMANCES without CC 1.4322

10052 PERFORMANCES on the THYROID and PŘÍŠTITNÉ GLAND, THYROGLOSSÁLNÍ PERFORMANCES with CC 1.6735

10053 PERFORMANCES on the THYROID and PŘÍŠTITNÉ GLAND, THYROGLOSSÁLNÍ PERFORMANCES with MCC 2.0576

10061 DIFFERENT PERFORMANCES in the ENDOCRINE, nutritional and metabolic DISORDERS without CC 2.6071

10062 OTHER ENDOCRINE, nutritional PERFORMANCE and metabolic DISORDERS with CC 3.2318

10063 OTHER ENDOCRINE, nutritional PERFORMANCE and metabolic DISORDERS with MCC 5.8681

10301 DIABETES, nutritional and other METABOLIC DISORDERS without CC 0.5348

10302 DIABETES, nutritional and other METABOLIC DISORDERS with CC 0.6489

10303 DIABETES, nutritional and other METABOLIC DISORDERS with MCC 0.8293

10311 HYPOVOLEMIA and ELECTROLYTE DISTURBANCES without CC 0.3777

10312 HYPOVOLEMIA and ELECTROLYTE DISTURBANCES with CC 0.5006

10313 HYPOVOLEMIA and ELECTROLYTE DISTURBANCES with MCC 0.5381

10321 CONGENITAL METABOLIC DISORDERS without CC 0.6562

10322 CONGENITAL METABOLIC DISORDERS with CC 0.9029

10323 CONGENITAL METABOLIC DISORDERS with MCC 1.8449

10331 OTHER ENDOCRINE DISORDERS without CC 0.6810

10332 OTHER ENDOCRINE DISORDERS with CC 0.6810

10333 OTHER ENDOCRINE DISORDERS with MCC 0.9772

11011 KIDNEY TRANSPLANTATION without CC 9.3263

11012 KIDNEY TRANSPLANTATION with CC 9.3263

11013 KIDNEY TRANSPLANT with MCC 10.3505

11021 GREAT PERFORMANCES on the BLADDER without CC 7.9821

11022 GREAT PERFORMANCES on the BLADDER with CC 7.9821

11023 GREAT PERFORMANCES on the BLADDER with MCC 10.9774

11031 GREAT PERFORMANCES on the KIDNEYS and the URINARY TRACT without CC 2.3232

11032 GREAT PERFORMANCES on the KIDNEYS and the URINARY TRACT with CC 2.7567

11033 GREAT PERFORMANCES on the KIDNEYS and the URINARY TRACT with MCC 3.8341

11041 OPERATING the ESTABLISHMENT or REVISION of the CATHETER for PERITONEAL DIALYSIS without CC 0.4703

11042 OPERATING the ESTABLISHMENT or REVISION of the CATHETER for PERITONEAL DIALYSIS with CC 0.6478

11043 OPERATING the ESTABLISHMENT or REVISION of the CATHETER for PERITONEAL DIALYSIS with MCC 1.8324

11051 LESS PERFORMANCES on the kidneys, URINARY TRACT and URINARY BLADDER without CC 1.2667

11052 LESS PERFORMANCES on the kidneys, URINARY TRACT and URINARY BLADDER with CC 1.3134

11053 LESS PERFORMANCES on the kidneys, URINARY TRACT and URINARY BLADDER with MCC 1.8144

11061 PROSTATECTOMY without CC 1.3700

11062 PROSTATECTOMY with CC 1.7634

11063 PROSTATECTOMY with MCC 1.8218

11071 URETHRAL and TRANSURETHRAL PERFORMANCES without CC 0.7019

11072 URETHRAL and TRANSURETHRAL PERFORMANCES with CC 0.7917

11073 URETHRAL and TRANSURETHRAL PERFORMANCES with MCC 1.0642

11081 OTHER PERFORMANCES with FAULTS and DISEASES of the kidney and urinary tract without CC 2.3063

11082 OTHER PERFORMANCES with FAULTS and DISEASES of the kidney and urinary tract with CC 3.2666

11083 OTHER PERFORMANCES with FAULTS and DISEASES of the kidney and urinary tract with MCC 6.6455

11301 MALIGNANT DISEASES of the kidneys and the urinary tract and KIDNEY FAILURE without CC 0.5265

11302 MALIGNANT DISEASES of the kidneys and the urinary tract and KIDNEY failure with CC 0.8204

11303 MALIGNANT DISEASES of the kidneys and the urinary tract and KIDNEY failure with MCC 1.3226

11311 NEPHRITIS without CC 0.5893

11312 NEPHRITIS with CC 0.6643

11313 NEPHRITIS with MCC 0.7229

11321 KIDNEY INFECTION and urinary tract without CC 0.4715

11322 KIDNEY INFECTION and urinary tract with CC 0.6615

11323 KIDNEY INFECTION and URINARY TRACT INFECTION with MCC 0.8405

11331 BLADDER STONES with EXTRACORPOREAL SHOCK WAVE LITOTRYPSÍ without-CC 0.5664

11332 BLADDER STONES with EXTRACORPOREAL SHOCK WAVE LITOTRYPSÍ with CC to 0.7284

11333 BLADDER STONES with EXTRACORPOREAL SHOCK WAVE LITOTRYPSÍ with MCC 1.1151

11341 BLADDER STONES without EXTRACORPOREAL LITOTRYPSE without-CC 0.3905

11342 BLADDER STONES without EXTRACORPOREAL LITOTRYPSE with CC to 0.5098

11343 BLADDER STONES without EXTRACORPOREAL LITOTRYPSE with MCC 0.6138

11351 failures, reactions and complications, GRAFT or GENITOURETRÁLNÍHO DEVICE 0.3500

THE TRANSPLANT WITHOUT CC

11352 failures, reactions and complications, GRAFT or GENITOURETRÁLNÍHO DEVICE 0.8626

THE TRANSPLANT WITH CC

11353 failures, reactions and complications, GRAFT or GENITOURETRÁLNÍHO DEVICE 3.8827

THE TRANSPLANT WITH MCC

11361 signs and symptoms on the KIDNEYS and the URINARY TRACT without CC 0.5806

11362 signs and symptoms of KIDNEY and URINARY TRACT with CC 0.5806

11363 signs and symptoms of KIDNEY and URINARY TRACT with MCC 0.5806

11371 OTHER kidney and urinary tract DISORDERS without CC 0.3676

11372 OTHER kidney and urinary tract DISORDERS with CC 0.4308

11373 OTHER kidney and urinary tract DISORDERS with MCC 0.6055

12011 BIG PERFORMANCES in the pelvis in a man without CC 2.3157

12012 BIG PERFORMANCES in the pelvis in a man with CC 2.5014

12013 BIG PERFORMANCES in the pelvis in a man with MCC 3.4334

12021 PERFORMANCES on the PENIS without CC 0.6171

12022 PERFORMANCES on the PENIS with CC 1.0346

12023 PERFORMANCES on the PENIS with MCC 1.0346

12031 TRANSURETHRAL PROSTATECTOMY without CC 1.2987

12032 TRANSURETHRAL PROSTATECTOMY with CC 1.4409

12033 TRANSURETHRAL PROSTATECTOMY with MCC 1.6939

12041 PERFORMANCES on the TESTICLES without CC 0.6157

12042 PERFORMANCES on the TESTICLES with CC 0.7981

12043 PERFORMANCES on the TESTICLES with MCC 0.8446

12051 CIRCUMCISION without CC 0.4390

12052 CIRCUMCISION with CC 0.4791

12053 CIRCUMCISION with MCC 0.5187

12061 OTHER PERFORMANCES on the MALE REPRODUCTIVE SYSTEM without CC 0.9163

12062 OTHER PERFORMANCES on the MALE REPRODUCTIVE SYSTEM with CC 1.0792

12063 OTHER PERFORMANCES on the MALE REPRODUCTIVE SYSTEM with MCC 1.6729

12301 MALIGNANT DISEASES of the MALE REPRODUCTIVE SYSTEM without CC 0.5522

12302 MALIGNANT DISEASES of the MALE REPRODUCTIVE SYSTEM with CC 0.7942

12303 MALIGNANT DISEASES of the MALE REPRODUCTIVE SYSTEM with MCC 0.9381

12311 DISORDERS of the MALE REPRODUCTIVE SYSTEM, in ADDITION to the MALIGNANT DISEASE without CC 0.2425

12312 DISORDERS of the MALE REPRODUCTIVE SYSTEM, in ADDITION to the MALIGNANT DISEASE with CC 0.3204

12313 DISORDERS of the MALE REPRODUCTIVE SYSTEM, in ADDITION to the MALIGNANT DISEASE with MCC 0.3451

13011 EXENTERACE PANS, RADICAL HYSTERECTOMY and radical VULVEKTOMIE BEZCC 3.9556

13012 EXENTERACE PANS, RADICAL HYSTERECTOMY and radical VULVEKTOMIE with CC to 4.4586

13013 EXENTERACE PANS, RADICAL HYSTERECTOMY and radical VULVEKTOMIE with MCC 4.6091

13021 PERFORMANCES on the womb and PAIN for MALIGNANT DISEASE on the OVARY and PAIN without CC 2.9797


13022 PERFORMANCES on the womb and PAIN for MALIGNANT DISEASE on the OVARY and PAIN with CC 3.3758

13023 PERFORMANCES on the womb and PAIN for MALIGNANT DISEASE on the OVARY and PAIN with MCC 6.4743

13031 PERFORMANCES on the womb and PAIN in MALIGNANT DISEASE, OTHER THAN on the OVARY and the 2.1566

PAIN WITHOUT CC

13032 PERFORMANCES on the womb and PAIN in MALIGNANT DISEASE, OTHER THAN on the OVARY and the 2.7803

PAIN WITH CC

13033 OUTPUTS to the womb and PAIN in MALIGNANT DISEASE, OTHER THAN on the OVARY and the 4.0851

PAIN WITH MCC

13041 UTERINE and ADNEXAL PERFORMANCES in CA IN SITU and BENIGN DISORDERS without CC 1.4904

13042 UTERINE and ADNEXAL PERFORMANCES in CA IN SITU and BENIGN DISORDERS with CC 1.7010

13043 UTERINE and ADNEXAL PERFORMANCES in CA IN SITU and BENIGN DISORDERS with MCC 2.2094

13051 GYNECOLOGICAL LAPAROSCOPY or STERILIZATION without LAPAROTOMICKÁ CC 0.7839

13052 GYNECOLOGICAL LAPAROSCOPY or STERILIZATION with CC LAPAROTOMICKÁ 1.0618

13053 GYNECOLOGICAL LAPAROSCOPY or LAPAROTOMICKÁ STERILIZATION with MCC 1.4398

13061 RECONSTRUCTIVE PERFORMANCES on the FEMALE REPRODUCTIVE SYSTEM without CC 1.0415

13062 RECONSTRUCTIVE PERFORMANCES on the FEMALE REPRODUCTIVE SYSTEM with CC 1.0539

13063 RECONSTRUCTIVE PERFORMANCES on the FEMALE REPRODUCTIVE SYSTEM with MCC 1.2261

13071 VAGINAL, CERVICAL and VULVOVÉ PERFORMANCES without CC 0.3662

13072 VAGINAL, CERVICAL and VULVOVÉ PERFORMANCES with CC 0.4928

13073 VAGINAL, CERVICAL and VULVOVÉ PERFORMANCES with MCC 0.6676

13081 ENDOSCOPIC INTERRUPTS the FALLOPIAN TUBE without CC 0.8259

13082 ENDOSCOPIC INTERRUPTS the FALLOPIAN TUBE with CC 0.8259

13083 ENDOSCOPIC INTERRUPTION of FALLOPIAN TUBE with MCC 0.8259

13091 dilation, CURETTAGE and KÓNIZACE without-CC 0.2845

13092 dilation, CURETTAGE and KÓNIZACE with CC to 0.3325

13093 dilation, CURETTAGE and KÓNIZACE with MCC 0.4283

13101 OTHER PERFORMANCES in DISORDERS and DISEASES of the FEMALE REPRODUCTIVE SYSTEM without CC 1.6135

13102 OTHER PERFORMANCES in DISORDERS and DISEASES of the FEMALE REPRODUCTIVE SYSTEM with CC 2.1500

13103 OTHER PERFORMANCES in DISORDERS and DISEASES of the FEMALE REPRODUCTIVE SYSTEM with MCC 4.1447

13301 MALIGNANT DISEASE of the FEMALE REPRODUCTIVE SYSTEM without CC 0.6355

13302 MALIGNANT DISEASE of the FEMALE REPRODUCTIVE SYSTEM with CC 0.6524

13303 MALIGNANT DISEASE of the FEMALE REPRODUCTIVE SYSTEM with MCC 0.8968

13311 INFECTION of the FEMALE REPRODUCTIVE SYSTEM without CC 0.3664

13312 INFECTION of the FEMALE REPRODUCTIVE SYSTEM with CC 0.5603

13313 INFECTION of the FEMALE REPRODUCTIVE SYSTEM with MCC 0.8657

13321 menstrual and OTHER DISORDERS of the FEMALE REPRODUCTIVE SYSTEM without CC 0.2386

13322 menstrual and OTHER DISORDERS of the FEMALE REPRODUCTIVE SYSTEM with CC 0.3400

13323 menstrual and OTHER DISORDERS of the FEMALE REPRODUCTIVE system with MCC 0.5136

14601 BIRTH CESAREAN SECTION without CC 1.2045

14602 BIRTH CESAREAN SECTION with CC 1.4349

14603 BIRTH CESAREAN SECTION with MCC 1.6040

14611 VAGINAL CHILDBIRTH, STERILIZATION and/or DILATION and KYRETÁŽÍ without-CC 0.6671

14612 VAGINAL CHILDBIRTH, STERILIZATION and/or DILATION and KYRETÁŽÍ with CC to 0.7524

14613 VAGINAL CHILDBIRTH, STERILIZATION and/or DILATION and KYRETÁŽÍ with MCC 0.7615

14621 VAGINAL CHILDBIRTH with the power, in ADDITION to sterilization and/or dilation and CURETTAGE without CC 0.8853

14622 VAGINAL CHILDBIRTH with the power, in ADDITION to sterilization and/or dilation and CURETTAGE with CC 2.7523

14623 VAGINAL CHILDBIRTH with the power, in ADDITION to sterilization and/or dilation and CURETTAGE with MCC 3.7439

14631 VAGINAL CHILDBIRTH without CC 0.4653

14632 VAGINAL CHILDBIRTH with CC 0.5085

14633 VAGINAL CHILDBIRTH with MCC 0.5085

14641 ABORTION with DILATION and KYRETÁŽÍ, a HYSTERECTOMIES KYRETÁŽÍ or without ASPIRATION CC 0.2697

14642 ABORTION with DILATION and KYRETÁŽÍ, a HYSTERECTOMIES KYRETÁŽÍ or ASPIRATION SCC 0.3406

14643 ABORTION with DILATION and KYRETÁŽÍ, ASPIRATION or HYSTERECTOMIES SMCC KYRETÁŽÍ 0.3406

14651 ABORTION without dilation and CURETTAGE, ASPIRATION CURETTAGE or HYSTEREKTOMIEBEZ CC 0.1277

14652 ABORTION without dilation and CURETTAGE, ASPIRATION CURETTAGE or HYSTEREKTOMIES CC 0.2216

14653 ABORTION without dilation and CURETTAGE, ASPIRATION CURETTAGE or HYSTEREKTOMIES MCC 0.3044

14661 POSTPARTUM and POPOTRATOVÉ performance DIAGNOSIS without CC 0.2708

14662 POSTPARTUM and POPOTRATOVÉ performance DIAGNOSIS with CC 0.3807

14663 POSTPARTUM and POPOTRATOVÉ performance DIAGNOSIS with MCC 0.4520

14671 POSTPARTUM and POPOTRATOVÉ DIAGNOSIS without EXERCISING without CC 0.2178

14672 POSTPARTUM and POPOTRATOVÉ DIAGNOSIS without PERFORMANCE with CC 0.2860

14673 POSTPARTUM and POPOTRATOVÉ DIAGNOSIS without MCC performance 0.2860

14681 ECTOPIC PREGNANCY with the performance without the CC 1.4639

14682 ECTOPIC PREGNANCY with the performance with CC 1.6946

14683 ECTOPIC PREGNANCY with the performance with MCC 2.9878

14691 ECTOPIC PREGNANCY without EXERCISING without CC 1.1601

14692 ECTOPIC PREGNANCY without PERFORMANCE with CC 1.4248

14693 ECTOPIC PREGNANCY without EXERCISING with MCC 1.4552

14701 THREATENED ABORTION without CC 0.3774

14702 THREATENED ABORTION with CC 0.5052

14703 THREATENED ABORTION with MCC 0.5052

14711 FAKE BIRTH without CC 0.1588

14712 FAKE BIRTH with CC 0.3778

14713 FAKE BIRTH with MCC 0.3778

14721 OTHER ANTENATAL DIAGNOSIS without CC performance 0.4083

14722 ANTENATAL DIAGNOSIS with OTHER PERFORMANCE with CC 0.7395

14723 OTHER ANTENATAL DIAGNOSES with MCC 1.0419 performance

OTHER ANTENATAL DIAGNOSIS 14731 without EXERCISING without CC 0.3110

OTHER ANTENATAL DIAGNOSIS without 14732 PERFORMANCE with CC 0.5296

OTHER ANTENATAL DIAGNOSIS without 14733 performance with MCC 0.5296

15601 newborn, DEAD or TRANSLATED without CC < 5 days 0.3036

15602 newborn, DEAD or TRANSLATED < 5 days with CC 2.2586

15603 newborn, DEAD or TRANSLATED < 5 days with MCC 5.1102

15611 newborn, with PLANTED or EXTRACORPOREAL MEMBRANE OXYGENACÍ without-CC 9.7958

15612 newborn, with PLANTED or EXTRACORPOREAL MEMBRANE OXYGENACÍ with CC to 13.7141

15613 a NEWBORN, with PLANTED or EXTRACORPOREAL MEMBRANE OXYGENACÍ with MCC 21.7956

15621 newborn, BIRTH WEIGHT 1000 g, with the BASIC < PERFORMANCE without CC 14.0406

15622 newborn, BIRTH WEIGHT 1000 g, with the BASIC < PERFORMANCE with CC 18.5304

15623 newborn, BIRTH WEIGHT 1000 g, with the BASIC < performance with MCC 26.0405

15631 newborn, BIRTH WEIGHT 1000 g, NO BASIC < PERFORMANCE without CC 18.4531

15632 newborn, BIRTH WEIGHT 1000 g, NO BASIC < PERFORMANCE with CC 21.9691

15633 newborn, BIRTH WEIGHT 1000 g, NO BASIC < performance with MCC 25.7012

15641 newborn, BIRTH WEIGHT 1000-1499G, with the BASIC PERFORMANCE without CC 3.3735

15642 newborn, BIRTH WEIGHT 1000-1499G, with the BASIC PERFORMANCE with CC 5.6668

15643 newborn, BIRTH WEIGHT 1000-1499G, with the BASIC performance with MCC 25.9828

15651 newborn, BIRTH WEIGHT 1000-1499G, without a BASIC PERFORMANCE without CC 11.2610

15652 newborn, BIRTH WEIGHT 1000-1499G, without a BASIC PERFORMANCE with CC 11.2610

15653 newborn, BIRTH WEIGHT 1000-1499G, without a BASIC performance with MCC 14.7248

15661 newborn, BIRTH WEIGHT 1500-1999G, VÝKONEMBEZ CC 15.7340

15662 newborn, BIRTH WEIGHT 1500-1999G, with the BASIC PERFORMANCE with CC 15.7340

15663 newborn, BIRTH WEIGHT 1500-1999G, with the BASIC performance with MCC 18.4144

15671 newborn, BIRTH WEIGHT 1500-1999G, without a BASIC PERFORMANCE without CC 4.7872

15672 newborn, BIRTH WEIGHT 1500-1999G, without a BASIC PERFORMANCE with CC 4.7905

15673 newborn, BIRTH WEIGHT 1500-1999G, without a BASIC performance with MCC 7.1666

15681 newborn, BIRTH WEIGHT 2000-2499G, with the BASIC PERFORMANCE without CC 9.3235

15682 newborn, BIRTH WEIGHT 2000-2499G, with the BASIC PERFORMANCE with CC 9.9334

15683 newborn, BIRTH WEIGHT 2000-2499G, with the BASIC performance with MCC 9.9334

15691 newborn, BIRTH WEIGHT 2000-2499G, without a BASIC PERFORMANCE without CC 1.0296

15692 newborn, BIRTH WEIGHT 2000-2499G, without a BASIC PERFORMANCE with CC 2.0251

15693 newborn, BIRTH WEIGHT 2000-2499G, without a BASIC performance with MCC 4.4301

15701 NEWBORN, weight at BIRTH, 2499G > PERFORMANCE without CC 3.8738

15702 a NEWBORN, weight at BIRTH, 2499G > PERFORMANCE with CC 7.2408

15703 a NEWBORN, weight at BIRTH, 2499G > performance with MCC 9.3861

15711 newborn, BIRTH WEIGHT > 2499G, with serious ANOMALIES or HEREDITARY STATUS without 0.6064

CC

15712 newborn, BIRTH WEIGHT > 2499G, with serious ANOMALIES or HEREDITARY STATUS with CC 1.2576

15713 newborn, BIRTH WEIGHT > 2499G, with serious ANOMALIES or HEREDITARY STATUS with 2.1598

MCC

15720 newborn, BIRTH WEIGHT > 2499G, with BREATHING DIFFICULTIES 2.7797

15731 NEWBORN, weight at BIRTH, with 2499G > ASPIRATION SYNDROME without the CC 0.4534

15732 NEWBORN, weight at BIRTH, with 2499G > ASPIRATION SYNDROME with CC 2.7838

15733 NEWBORN, weight at BIRTH, with 2499G > ASPIRATION SYNDROME with MCC 4.9587

15741 NEWBORN, weight at BIRTH, congenital 2499G > or PERINATAL INFECTIONS without CC 0.9037


15742 NEWBORN, weight at BIRTH, congenital 2499G > or PERINATAL INFECTIONS with CC 0.9037

15743 NEWBORN, weight at BIRTH, congenital 2499G > or PERINATAL INFECTION with MCC 2.2048

15751 NEWBORN, weight at BIRTH, without a BASIC 2499G > PERFORMANCE without CC 0.3979

15752 newborn, BIRTH WEIGHT > 2499G, without a BASIC PERFORMANCE with CC 0.5147

15753 newborn, BIRTH WEIGHT > 2499G, without a BASIC performance with MCC 0.5817

16011 PERFORMANCES on SPLEEN without CC 2.7542

16012 PERFORMANCES on SPLEEN with CC 3.6970

16013 PERFORMANCES on SPLEEN with MCC 6.3607

16021 OTHER PERFORMANCES for BLOOD DISEASES and BLOOD-FORMING ORGANS without CC 1.0326

16022 OTHER PERFORMANCES for BLOOD DISEASES and BLOOD-FORMING organs with CC 1.2198

16023 OTHER PERFORMANCES for BLOOD DISEASES and BLOOD-FORMING organs with MCC 3.7997

16301 AGRANULOCYTOSIS without CC 1.2485

16302 AGRANULOCYTOSIS with CC 1.7070

16303 AGRANULOCYTOSIS with MCC 3.3958

16311 CLOTTING DISORDER without CC 0.9309

16312 CLOTTING DISORDER with CC 1.5257

16313 CLOTTING DISORDER with MCC 2.0088

16321 SICKLE CELL ANAEMIA without CC 0.6449

16322 SICKLE CELL ANEMIA with CC 0.8816

16323 SICKLE CELL ANEMIA with MCC 1.4041

16331 DISORDERS of RED BLOOD CELLS, in ADDITION to the SICKLE CELL ANAEMIA without CC 0.7890

16332 DISORDERS of RED BLOOD CELLS, in ADDITION to the SICKLE CELL ANEMIA with CC 0.8813

16333 DISORDERS of RED BLOOD CELLS, in ADDITION to the SICKLE CELL ANEMIA with MCC 1.2320

16341 OTHER blood and HEMATOPOIETIC ORGANS without CC 0.6296

16342 OTHER blood and BLOOD-FORMING organs with CC 0.8054

16343 OTHER blood and BLOOD-FORMING organs with MCC 2.2254

17011 LYMPHOMA and LEUKEMIA with HIGH PERFORMANCE without CC 1.5945

17012 LYMPHOMA and LEUKEMIA with HIGH PERFORMANCE with CC 5.2622

17013 LYMPHOMA and LEUKEMIA with HIGH PERFORMANCE with MCC 8.0771

17021 LYMPHOMA and LEUKEMIA with another PERFORMANCE without CC 1.2213

17022 LYMPHOMA and LEUKEMIA with another PERFORMANCE with CC 1.7262

17023 LYMPHOMA and LEUKEMIA with another performance with MCC 8.3899

17031 MYELOPROLIFERATIVE disorders and POORLY DIFFERENTIATED TUMORS with HIGH PERFORMANCE without 2.6079

CC

17032 MYELOPROLIFERATIVE disorders and POORLY DIFFERENTIATED TUMORS with HIGH PERFORMANCE with CC 3.6115

17033 MYELOPROLIFERATIVE disorders and POORLY DIFFERENTIATED TUMORS with HIGH PERFORMANCE with MCC 8.7045

17041 MYELOPROLIFERATIVE disorders and POORLY DIFFERENTIATED TUMORS with another PERFORMANCE without CC 2.6052

17042 MYELOPROLIFERATIVE disorders and POORLY DIFFERENTIATED TUMORS with another PERFORMANCE with CC 3.2048

17043 MYELOPROLIFERATIVE disorders and POORLY DIFFERENTIATED TUMORS with another performance with MCC 4.6114

17301 ACUTE LEUKEMIA without CC 1.7535

17302 ACUTE LEUKEMIA with CC 1.8164

17303 ACUTE LEUKEMIA with MCC 11.0888

17311 LYMPHOMA and LEUKEMIA without EMERGENT CC 1.0727

17312 LYMPHOMA and LEUKEMIA with CC EMERGENT 1.1519

17313 LYMPHOMA and LEUKEMIA with EMERGENT MCC 2.9304

17321 RADIOTHERAPY without CC 1.4970

17322 RADIOTHERAPY with CC 1.4970

17323 RADIOTHERAPY with MCC 2.5432

17331 CHEMOTHERAPY without CC 0.5844

17332 CHEMOTHERAPY with CC 0.7685

17333 chemotherapy with MCC 1.1586

17341 OTHER MYELOPROLIFERATIVE disorders and DIAGNOSIS of UNDIFFERENTIATED TUMORS without CC 0.7414

17342 OTHER MYELOPROLIFERATIVE disorders and DIAGNOSIS of UNDIFFERENTIATED TUMORS with CC 0.7672

17343 OTHER MYELOPROLIFERATIVE disorders and DIAGNOSIS of UNDIFFERENTIATED TUMORS with MCC 1.4545

18011 PERFORMANCES for infectious and parasitic diseases without CC 0.4600

18012 PERFORMANCES for infectious and parasitic diseases with CC 4.6989

18013 PERFORMANCES for infectious and parasitic diseases with MCC 11.0578

18021 PERFORMANCES for post-operative and POST-TRAUMATIC INFECTIONS without CC 1.2965

18022 PERFORMANCES for post-operative and POST-TRAUMATIC infections with CC 1.5690

18023 PERFORMANCES for post-operative and POST-TRAUMATIC infections with MCC 3.7496

18301 SEPTICEMIA without CC 1.6049

18302 SEPTICEMIA with CC 1.6049

18303 SEPTICEMIA with MCC 3.3126

18311 post-operative and POST-TRAUMATIC INFECTIONS without CC 0.6687

18312 post-operative and POST-TRAUMATIC infections with CC 0.6815

18313 post-operative and POST-TRAUMATIC infections with MCC 1.2332

18321 FEVER of UNKNOWN ORIGIN with NO CC 0.4990

18322 FEVER of UNKNOWN ORIGIN with CC 0.7014

18323 FEVER of UNKNOWN ORIGIN with MCC 0.8780

18331 VIRAL DISEASE without CC 0.5210

18332 VIRAL DISEASE with CC 0.6765

18333 VIRAL DISEASE with MCC 0.7385

18341 other infectious and PARASITIC DISEASES without CC 0.6951

18342 OTHER INFECTIOUS and parasitic diseases with CC 1.0270

18343 OTHER INFECTIOUS and parasitic diseases with MCC 1.9560

19011 OPERATING PERFORMANCE with the principal DIAGNOSIS of MENTAL ILLNESS without CC 1.6424

19012 OPERATING PERFORMANCE with the principal DIAGNOSIS of MENTAL ILLNESS with CC 2.4313

19013 OPERATING PERFORMANCE with the principal DIAGNOSIS of MENTAL ILLNESS with MCC 5.3754

19301 SCHIZOPHRENIA without CC 1.3841

19302 SCHIZOPHRENIA with CC 1.9730

19303 SCHIZOPHRENIA with MCC 2.1149

19311 PSYCHOSIS without CC 1.3775

19312 CC of PSYCHOSIS with 1.4254

19313 PSYCHOSIS with MCC 1.5908

19321 PERSONALITY DISORDERS and mood without CC 0.8606

19322 PERSONALITY DISORDERS and mood with CC 1.0315

19323 PERSONALITY DISORDERS and mood with MCC 1.5133

19331 BIPOLAR DISORDERS without CC 1.5384

19332 BIPOLAR DISORDERS with CC 1.7090

19333 BIPOLAR DISORDERS with MCC 2.5019

19341 DEPRESSION without CC 0.7245

19342 DEPRESSION with CC 1.0813

19343 DEPRESSION with MCC 1.6135

19351 ACUTE REACTIONS, PSYCHO-SOCIAL disorders and NEUROSIS in ADDITION to DEPRESSIVE without CC 0.6112

19352 ACUTE REACTIONS, PSYCHO-SOCIAL disorders and NEUROSIS in ADDITION to DEPRESSIVE with CC 0.6553

19353 ACUTE REACTIONS, PSYCHO-SOCIAL disorders and NEUROSIS in ADDITION to DEPRESSIVE with MCC 0.6856

19361 ORGANIC MENTAL DISORDERS and mental retardation without CC 0.9639

19362 ORGANIC MENTAL DISORDERS and mental retardation with CC 0.9672

19363 ORGANIC MENTAL DISORDERS and mental retardation with MCC 1.3330

19371 DEVELOPMENTAL PSYCHIATRIC DISORDERS without CC 0.9889

19372 DEVELOPMENTAL MENTAL DISORDERS with CC 0.9889

19373 DEVELOPMENTAL MENTAL DISORDERS with MCC 1.4022

19381 COMPULSIVE NUTRITIONAL DISORDERS without CC 2.3071

19382 COMPULSIVE NUTRITIONAL DISORDERS with CC 2.3071

19383 COMPULSIVE NUTRITIONAL DISORDERS with MCC 2.8580

19391 OTHER MENTAL DISORDERS without CC 0.7644

19392 OTHER MENTAL DISORDERS with CC 0.8276

19393 OTHER MENTAL DISORDERS with MCC 1.6789

20301 the HARMFUL USE of ALCOHOL, DRUGS, drugs, addiction on them, RELEASE AGAINST 0.2384

THE DOCTOR'S RECOMMENDATIONS WITHOUT CC

20302 the HARMFUL USE of ALCOHOL, DRUGS, drugs, addiction on them, RELEASE AGAINST 0.2537

THE DOCTOR'S RECOMMENDATIONS WITH CC

20303 HARMFUL USE of ALCOHOL, DRUGS, drugs, addiction on them, RELEASE AGAINST 0.2537

THE DOCTOR'S RECOMMENDATIONS WITH MCC

20311 a DEPENDENCY on drugs and alcohol rehabilitation and/or DETOX THERAPIES without CC 0.8000

20312 DEPENDENCY on drugs and alcohol rehabilitation and/or DETOXIFICATION THERAPIES with CC 0.8571

20313 DEPENDENCY on drugs and alcohol rehabilitation and/or DETOXIFICATION THERAPIES with MCC 0.9306

20321 HARMFUL use and DEPENDENCE on OPIATES and/or COCAINE without CC 0.7648

20322 HARMFUL use and DEPENDENCE on OPIATES and/or COCAINE with CC 0.7648

20323 HARMFUL use and DEPENDENCE on OPIATES and/or COCAINE with MCC 5.8964

20331 HARMFUL use and DEPENDENCE on ALCOHOL without CC 0.3741

20332 HARMFUL use and DEPENDENCE on ALCOHOL with CC 0.4569

20333 HARMFUL use and DEPENDENCE on ALCOHOL with MCC 1.5169

20341 HARMFUL use and DEPENDENCE on OTHER DRUGS without CC 0.6131

20342 HARMFUL use and DEPENDENCE on OTHER DRUGS with CC 0.6131

20343 HARMFUL use and DEPENDENCE on OTHER DRUGS with MCC 1.0951

21011 MICROVASCULAR TISSUE TRANSFER or SKIN GRAFT when INJURIES without CC 1.1682

21012 MICROVASCULAR TISSUE TRANSFER or a SKIN GRAFT at ACCIDENTS with CC 2.6911

21013 MICROVASCULAR TISSUE TRANSFER or a SKIN GRAFT at ACCIDENTS with MCC 9.7516

21021 OTHER PERFORMANCES at ACCIDENTS and COMPLICATIONS without CC 1.8442

21022 OTHER PERFORMANCES at ACCIDENTS and COMPLICATIONS with CC 2.7625

21023 OTHER PERFORMANCES at ACCIDENTS and COMPLICATIONS with MCC 7.6663

21301 INJURY on an UNDETERMINED LOCATION or in MULTIPLE PLACES without CC 2.4332

21302 INJURIES to an UNSPECIFIED LOCATION, or at SEVERAL LOCATIONS with CC 2.4332

21303 INJURIES to an UNSPECIFIED LOCATION, or at SEVERAL LOCATIONS with MCC 7.8196

21311 ALLERGIC REACTIONS without CC 0.1972

21312 allergic reactions with CC 0.2693

21313 allergic reactions with MCC 0.3690

21321 poisoning and TOXIC EFFECTS of drugs (drugs) without CC 0.2624

21322 poisoning and TOXIC EFFECTS of drugs (drugs) with CC 0.4350

21323 poisoning and TOXIC EFFECTS of drugs (drugs) with MCC 0.9160

21331 the COMPLICATIONS in the TREATMENT without CC 0.3111

21332 COMPLICATIONS when TREATING with CC 0.4579

21333 COMPLICATIONS when TREATING with MCC 0.6371

21341 MALTREATED the CHILD or ADULT SYNDROME without the CC 0.4566

21342 SYNDROME of the ABUSED CHILD or ADULT with CC 1.9586

21343 SYNDROME of the ABUSED CHILD or ADULT with MCC 1.9586

21351 OTHER DIAGNOSES of INJURIES, poisoning and TOXIC EFFECTS without CC 0.3476

21352 OTHER DIAGNOSES of INJURIES, poisoning and TOXIC EFFECTS with CC 0.4225


21353 OTHER DIAGNOSIS of INJURIES, poisoning and TOXIC EFFECTS with MCC 1.0752

22501 BURNS, transfer to ANOTHER ACUTE CARE FACILITY without CC 11.4585

22502 BURNS, transfer to ANOTHER ACUTE CARE FACILITY with CC 23.5573

22503 BURNS, transfer to ANOTHER ACUTE CARE FACILITY with MCC 23.5573

22510 EXTENSIVE BURNS with SKIN GRAFT 9.0611

22521 NEROZSÁHLÉ BURNS through the ENTIRE skin with SKIN GRAFT or INHAL. INJURIES without 3.3751

CC

22522 NEROZSÁHLÉ BURNS through the ENTIRE skin with SKIN GRAFT or INHAL. INJURY with 7.3348

CC

22523 NEROZSÁHLÉ BURNS through the ENTIRE skin with SKIN GRAFT or INHAL. INJURY with 12.0051

MCC

22530 EXTENSIVE BURNS without SKIN GRAFT 4.5278

22541 BURNS LIMITED SCOPE AFFECTING ALL LAYERS of the skin without SKIN GRAFT 0.9102

OR INHALED INJURY WITHOUT CC

22542 BURNS LIMITED SCOPE AFFECTING ALL LAYERS of the skin without SKIN GRAFT 1.9672

OR INHALED INJURY WITH CC

22543 BURNS LIMITED SCOPE AFFECTING ALL LAYERS of the skin without SKIN GRAFT 2.5611

OR INHALED INJURY WITH MCC

22551 BURNS LIMITED SCOPE of ALL LAYERS of the SKIN without NON-CC 0.9498

22552 BURNS LIMITED SCOPE of ALL LAYERS of the skin with NON-CC 1.6484

22553 BURNS LIMITED SCOPE of ALL LAYERS of the skin with NON-MCC 1.6484

23011 OPERATING PERFORMANCE with a diagnosis of ANOTHER CONTACT with HEALTHCARE SLUŽBAMIBEZ CC 0.7265

23012 OPERATING PERFORMANCE with a diagnosis of ANOTHER CONTACT with HEALTHCARE SLUŽBAMIS CC 2.0306

23013 OPERATING PERFORMANCE with a diagnosis of ANOTHER CONTACT with HEALTHCARE SLUŽBAMIS MCC 6.2936

23301 REHABILITATION without CC 1.0090

23302 REHABILITATION with CC 1.1237

23303 REHABILITATION with MCC 1.2273

23311 symptoms and ABNORMAL FINDINGS without CC 0.4180

23312 symptoms and ABNORMAL FINDINGS with CC 0.5787

23313 symptoms and ABNORMAL FINDINGS with MCC 0.6642

23321 OTHER FACTORS AFFECTING HEALTH STATUS without CC 0.2803

23322 OTHER FACTORS AFFECTING HEALTH STATUS with CC 0.5618

23323 OTHER FACTORS AFFECTING HEALTH STATUS with MCC 1.1027

24010 HIV with the performance, with several SEVERE INFECTIONS ASSOCIATED with HIV 0.8707

24020 HIV with the performance, with an additional DIAGNOSIS of HIV-related 2.2247

24031 HIV with power, without FURTHER DIAGNOSIS RELATED with HIV without CC 0.3359

24032 HIV with power, without an ADDITIONAL DIAGNOSIS of HIV related with CC 0.3359

24033 HIV with power, without an ADDITIONAL DIAGNOSIS of HIV related with MCC 0.3359

24301 HIV with VENTILATION or NUTRITIONAL SUPPORT without CC 4.7206

24302 HIV with VENTILATION or NUTRITIONAL SUPPORT with CC 4.7206

24303 HIV with VENTILATION or NUTRITIONAL SUPPORT with MCC 4.7206

24311 HIV with OTHER HIV-related DIAGNOSIS, RELEASED through the MEDICAL RECOMMENDATIONS without 0.4735

CC

24312 HIV with another DIAGNOSIS related to HIV, RELEASED through the MEDICAL RECOMMENDATIONS with CC 0.7510

24313 HIV with OTHER HIV-related DIAGNOSIS, RELEASED through the MEDICAL recommendations with 1.1837

MCC

24320 HIV with several SEVERE INFECTIONS ASSOCIATED with HIV 0.7347

24331 HIV with OTHER HIV-related DIAGNOSIS, without a FEW SERIOUS INFECTIONS 1.7500

HIV-RELATED TUBERCULOSIS WITHOUT CC

24332 HIV with OTHER HIV-related DIAGNOSIS, without a FEW SERIOUS INFECTIONS 1.7500

HIV-RELATED TUBERCULOSIS WITH CC

24333 HIV with another DIAGNOSIS related to HIV, without a FEW SERIOUS INFECTIONS 1.7500

HIV-RELATED TUBERCULOSIS WITH MCC

24341 HIV with OTHER HIV-related DIAGNOSIS, without a FEW SERIOUS INFECTIONS 0.6383

RELATED TO HIV, TUBERCULOSIS-FREE WITHOUT CC

24342 HIV with OTHER HIV-related DIAGNOSIS, without a FEW SERIOUS INFECTIONS 0.6383

RELATED TO HIV, TUBERCULOSIS-FREE WITH CC

24343 HIV with another DIAGNOSIS related to HIV, without a FEW SERIOUS INFECTIONS 0.6383

RELATED TO HIV, TUBERCULOSIS-FREE WITH MCC

24350 HIV without FURTHER DIAGNOSIS HIV-related 0.5699

25011 CRANIOTOMY, a LARGE PERFORMANCE on the SPINE, HIP and ENDS. When MULTIPLE SEVERE 8.6354

TRAUMA WITHOUT CC

25012 CRANIOTOMY, a LARGE PERFORMANCE on the SPINE, HIP and ENDS. When MULTIPLE SEVERE 8.6354

TRAUMA WITH CC

25013 CRANIOTOMY, a LARGE PERFORMANCE on the SPINE, HIP and ENDS. When MULTIPLE SEVERE 15.7720

TRAUMA WITH MCC

25021 OTHER PERFORMANCES in MULTIPLE SIGNIFICANT TRAUMA without CC 5.8418

25022 OTHER PERFORMANCES in MULTIPLE SIGNIFICANT TRAUMA with CC 5.8418

25023 OTHER PERFORMANCES in MULTIPLE SIGNIFICANT TRAUMA with MCC 12.8075

25301 DIAGNOSIS on the HEAD, chest and leg when MULTIPLE SEVERE 0.9668

TRAUMA WITHOUT CC

25302 DIAGNOSIS on the HEAD, chest and leg when MULTIPLE SEVERE 1.1460

TRAUMA WITH CC

25303 DIAGNOSIS on the HEAD, chest and leg when MULTIPLE SEVERE 2.3153

TRAUMA WITH MCC

the DIAGNOSIS of MULTIPLE MYELOMA, OTHER SERIOUS 25311 TRAUMA without CC 1.1735

the DIAGNOSIS of MULTIPLE MYELOMA, OTHER SERIOUS 25312 TRAUMA with CC 1.3023

the DIAGNOSIS of MULTIPLE MYELOMA, OTHER SERIOUS 25313 TRAUMA with MCC 2.3381

88871 EXTENSIVE performances that DO NOT RELATE to the MAIN DIAGNOSIS without CC 1.1598

88872 EXTENSIVE performances that DO NOT RELATE to the MAIN DIAGNOSIS with CC 2.8373

88873 EXTENSIVE performances that DO NOT RELATE to the MAIN DIAGNOSES with MCC 6.4976

88881 PROSTATIC performances that DO NOT RELATE to the MAIN DIAGNOSIS without CC 1.0503

88882 PROSTATIC performances that DO NOT RELATE to the MAIN DIAGNOSIS with CC 1.0910

88883 PROSTATIC performances that DO NOT RELATE to the MAIN DIAGNOSES with MCC 2.2361

88891 PERFORMANCES of LIMITED SCOPE which does not concern the MAIN DIAGNOSIS without CC 0.5541

88892 PERFORMANCES of LIMITED SCOPE which does not concern the MAIN DIAGNOSES with CC 1.1476

88893 PERFORMANCES of LIMITED SCOPE which does not concern the MAIN DIAGNOSES with MCC 2.3088

99980 MAIN DIAGNOSIS INVALID AS LAYOFF DIAGNOSIS 0.4184

99990-0.4061

-------- --------------------------------------------------------------------------------- ------------



3.3 Basic lump-sum payment (PUZ2008) by 31.5.2009

converted, and the conversion includes health care, which was

the medical establishment for 2008 is reported not later than 31 March 2009 and

health insurance company recognized as follows:



PUP2008 = PUZhosp2008 * (1-CMalfa/CMtot) + CMalfa * ZS + PUZamb2008



where:



PUP2008 flat-rate remuneration calculated base



PUZhosp2008 part of the base flat-rate remuneration PUZ2008 for

hospital costs, which shall be as follows:



PUZhosp2008 = PUZhosp2007 * Kn



PUZhosp2007 = Vhosp * ICBref + ZUMhosp + ZULPhosp + LPhosp + KPhosp



Vhosp the total number of medical facilities

in 2007, the reported and health insurance company

recognised for services performed during the

hospitalizations, including performances in the listed

fields of medicine and consult with the examination, in accordance with

list of performances, after the deduction of points for performance

(including performances in the listed fields of medicine

and consult with the examination, according to the list of performances)

made in 2007, during the hospitalizations,

that is according to the classification included in the

the listed groups



ZUMhosp the total amount of the reimbursement of medical

the device reported and health insurance company

recognised separately posted material provided

in 2007 in connection with the performances, made

during hospitalization, with the exception of separately

the posted material provided in 2007

in connection with the performances, that were made during the

hospitalizations, which are according to the classification

included in the listed groups



ZULPhosp the total amount of the reimbursement of medical

the device reported and health insurance company

recognised separately charged to medicinal products

rendered in 2007 in connection with the performances,

made during the hospitalization, with the exception of

separately charged to medicinal products

awarded in 2007 in connection with the performances,

made during the hospitalizations, which are

According to the classification included in the listed

groups



LPhosp flat-rate amount shall be paid to the healing

preparations for ošetřovacím days and reported

health insurance company recognized for the year 2007,

with the exception of the flat-rate amounts to ošetřovacím days

reported for the year 2007 during hospitalizations, which

are according to the classification included in the listed

groups



KPhosp other health care paid in Czech Crowns

(in addition to ZUMhosp, ZULPhosp and LPhosp) and declared

health insurance company recognized, provided

medical facilities in 2007 during the

hospital admissions, with the exception of health care

rendered in 2007 during the hospitalizations,

that is according to the classification included in the

the listed groups



CMalfa number of cases, hospitalizations terminated in 2008,

which are classified according to the classification into groups


related to the diagnosis, multiplied by the indexes that

are given in section 3.4.



CMtot number of cases, hospitalizations terminated in 2008,

included in the Classification of groups related to the

diagnosis, multiplied by the indexes that are listed

in section 3.2, except in cases of hospitalization, which

are according to the classification included in the listed

groups



WS basic rate for 2008 is set at EUR 20 413 €



PUZamb2008 part of the flat-rate payment of PUZ2008 for outpatients

care, which counts all health care

provided to out-patients, including health care in

the listed fields of medicine and consult with an examination,

According to the list of performances, calculated as follows:



PUZamb2008 = PUZ2008-PUZhosp2008



3.4 Group related to the diagnosis according to the classification with indexes, used to

calculating the value of CMalfa, as referred to in section 3.3:

------ --------------------------------------------------------- ---------

IR-DRG5) group name Index

------ --------------------------------------------------------- ---------

01051 CARPAL TUNNEL RELEASE without CC 0.1705

01052 CARPAL TUNNEL RELEASE with CC 0.2192

01053 CARPAL TUNNEL RELEASE with MCC 0.2327

01451 CONCUSSION without CC 0.2502

01452 CONCUSSION with CC 0.2904

01453 CONCUSSION with MCC 0.4669

02041 PERFORMANCES on the LENS with or without VITREKTOMIE without-CC 0.5243

02042 the PERFORMANCES on the LENS with or without VITREKTOMIE with CC 0.5719

02043 PERFORMANCES on the LENS with or without VITREKTOMIE with the MCC 0.5719

03061 PERFORMANCES on SALIVARY GLAND without CC 1.0647

03062 PERFORMANCES on SALIVARY GLAND with CC 1.3239

PERFORMANCES on the SALIVARY GLAND 03063 with MCC 1.3773

05021 PERFORMANCES on the HEART with the HEART-CATH LAB FLAP without CC 16.7875

05022 PERFORMANCES on the HEART with the HEART-CATH LAB FLAP with CC 22.0351

05023 PERFORMANCES on the HEART with the HEART-CATH LAB FLAP with MCC 22.2832

05041 PERFORMANCES on HEART FLAP without CARDIAC CATHETERIZATION without CC 14.5375

05042 PERFORMANCES on HEART FLAP without CARDIAC CATHETERIZATION with CC 16.3142

05043 PERFORMANCES on HEART FLAP without cardiac catheterization with MCC 18.6424

05051 CORONARY BYPASS SURGERY with HEART-CATH LAB without CC 12.0895

05052 CORONARY BYPASS SURGERY with HEART-CATH LAB with CC 14.0417

05053 CORONARY BYPASS SURGERY with HEART-CATH LAB with MCC 15.0073

05061 CORONARY BYPASS SURGERY without CARDIAC CATHETERIZATION without CC 10.0195

05062 CORONARY BYPASS SURGERY without CARDIAC CATHETERIZATION with CC 10.4284

05063 CORONARY BYPASS SURGERY without cardiac catheterization with MCC 12.5552

05101 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE with acute MYOCARDIAL 6.9680

INFARCTION WITHOUT CC

05102 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE with acute MYOCARDIAL 7.0606

INFARCTION WITH CC

05103 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE with acute MYOCARDIAL 8.0973

INFARCTION WITH MCC

IMPLANTATION of PERMANENT PACEMAKER 05111 without ACUTE 6.5566

MYOCARDIAL INFARCTION, HEART FAILURE OR SHOCK WITHOUT CC

IMPLANTATION of PERMANENT PACEMAKER 05112 without ACUTE 6.5566

MYOCARDIAL INFARCTION, HEART FAILURE OR SHOCK WITH CC

IMPLANTATION of PERMANENT PACEMAKER 05113 without ACUTE 7.2851

MYOCARDIAL INFARCTION, HEART FAILURE OR SHOCK WITH MCC

05131 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE MYOCARDIAL 5.7124

INFARCTION WITHOUT CC

05132 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE MYOCARDIAL 5.8581

INFARCTION WITH CC

05133 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE MYOCARDIAL 6.4009

INFARCTION WITH MCC

05311 CARDIAC CATHETERIZATION in the ISCHEMIC HEART without CC 1.0102

05312 CARDIAC CATHETERIZATION in the ISCHEMIC HEART with CC 1.1061

05313 CARDIAC CATHETERIZATION in the ISCHEMIC HEART with MCC 1.2632

06011 BIG PERFORMANCES on the THICK and THIN INTESTINE without CC 3.6731

GREAT PERFORMANCES on the THICK 06012 and THIN INTESTINE with CC 4.2191

06013 BIG PERFORMANCES on the THICK and THIN INTESTINE with MCC 5.6110

06051 PERFORMANCES on APENDIXU without-CC 1.0370

06052 PERFORMANCES at APENDIXU with CC to 1.2758

06053 PERFORMANCES on APENDIXU with MCC 1.8180

LAPAROTOMICKÉ PERFORMANCE 06081 INGUINAL, Femoral, UMBILICAL 0.7236

OR EPIGASTRIC HERNIA WITHOUT CC

LAPAROTOMICKÉ PERFORMANCE 06082 INGUINAL, Femoral, UMBILICAL 1.0194

OR EPIGASTRIC HERNIA WITH CC

LAPAROTOMICKÉ PERFORMANCE 06083 INGUINAL, Femoral, UMBILICAL 1.3567

OR EPIGASTRIC HERNIA WITH MCC

07041 LAPAROSCOPIC CHOLECYSTECTOMY without CC 1.6302

07042 LAPAROSCOPIC CHOLECYSTECTOMY with CC 1.8555

07043 LAPAROSCOPIC CHOLECYSTECTOMY with MCC 2.2424

SPINAL FUSION 08031, not for the DEFORMITY without CC 6.9862

08032 FUSION spine, NOT for DEFORMITY with CC 8.7586

08033 FUSION of the SPINE, not for DEFORMITY with MCC 10.5248

08081 PERFORMANCES on the HIPS and thigh BONES, in ADDITION to the REPLANTACE 2.6233

LARGE JOINTS WITHOUT CC

08082 PERFORMANCES on the HIPS and thigh BONES, in ADDITION to the REPLANTACE 3.1903

LARGE JOINTS WITH CC

08083 PERFORMANCES on the HIPS and thigh BONES, in ADDITION to the REPLANTACE 3.9092

LARGE JOINTS WITH MCC

10051 PERFORMANCES on the THYROID gland and PŘÍŠTITNÉ THYROGLOSSÁLNÍ PERFORMANCE 1.4322

WITHOUT CC

10052 PERFORMANCES on the THYROID gland and PŘÍŠTITNÉ THYROGLOSSÁLNÍ PERFORMANCE 1.6735

WITH CC

10053 PERFORMANCES on the THYROID gland and PŘÍŠTITNÉ THYROGLOSSÁLNÍ PERFORMANCE 2.0576

WITH MCC

12031 TRANSURETHRAL PROSTATECTOMY without CC 1.2987

12032 TRANSURETHRAL PROSTATECTOMY with CC 1.4409

12033 TRANSURETHRAL PROSTATECTOMY with MCC 1.6939

13091 dilation, CURETTAGE and KÓNIZACE without-CC 0.2845

13092 dilation, CURETTAGE and KÓNIZACE with CC to 0.3325

13093 dilation, CURETTAGE and KÓNIZACE with MCC 0.4283

14601 BIRTH CESAREAN SECTION without CC 1.2045

14602 BIRTH CESAREAN SECTION with CC 1.4349

14603 BIRTH CESAREAN SECTION with MCC 1.6040

14631 VAGINAL CHILDBIRTH without CC 0.4653

14632 VAGINAL CHILDBIRTH with CC 0.5085

14633 VAGINAL CHILDBIRTH with MCC 0.5085

15751 NEWBORN, weight at BIRTH, without a BASIC 2499G > 0.3979

PERFORMANCE WITHOUT CC

15752 NEWBORN, weight at BIRTH, without a BASIC 2499G > 0.5147

PERFORMANCE WITH CC

15753 NEWBORN, weight at BIRTH, without a BASIC 2499G > 0.5817

PERFORMANCE WITH MCC

------ --------------------------------------------------------- ---------



3.5 the above flat-rate reimbursement of the resulting folder (PUV2008)

medical equipment in 2008, equal to the amount of the calculated base

the flat-rate compensation (PUP2008), if the base flat-rate remuneration is calculated

(PUP2008) will not be in the appropriate half of 2008 less than 104% share

the base flat-rate remuneration and the coefficient of increase (PUZ2008/CN) and at the same time

will not be higher than 106% of this share.



3.6 If the base flat-rate remuneration calculated (PUP2008) will be less than

104% of the base flat-rate remuneration and koeficintu growth

(PUZ2008/CN), the resulting lump-sum payment of as PUV2008 folder

min as follows:



PUV2008 min = 1.04 * (PUZ2008/CN)



3.7 If a flat-rate remuneration calculated base (PUP2008) will be greater than the

106% of the base flat-rate remuneration and the coefficient of increase in

(PUZ2008/CN), the resulting lump-sum payment of as PUV2008 folder

Max as follows:

PUV2008 max = 1.06 (PUZ2008/CN)



3.8 the resulting lump payment folder (PUV2008), or

PUV2008 min or max PUV2008 belongs to the medical device, if:



3.8.1 the medical facility and is reported by the health insurance fund shall recognise a number of

hospital admissions for the year 2008 included in the groups related to the diagnosis of

According to the classification, multiplied by the Indexes, which are listed in section 3.2, in the

of at least 95% of the medical facilities reported and health

insurance recognised in the number of hospital admissions for the year 2007 included in the

groups related to the diagnosis, multiplied by the indexes of the classification,

that are listed in section 3.2; in an investigational or reference period

do not count towards hospitalization, which are classified according to the classification

the listed groups,



3.8.2 medical device reports and health insurance fund recognised by the number of

points for performance is provided in the out-patient care for the year 2008 in the amount of

at least 95% of the medical facilities reported and health insurance company

recognised the number of points for performance granted under the ambulatory care per year

2007.



3.9 If the medical establishment reported and health insurance company

recognized by the number of hospital admissions for the year 2008 included in the groups of related

to the diagnosis by classification, multiplied by the Indexes, which are listed in the

section 3.2, will be less than 95% of medical facilities reported and

health insurance company recognized the number of hospital admissions for the year 2007

included in the groups related to the diagnosis according to the classification,

multiplied by the Indexes, which are listed in section 3.2, the resulting lump

remuneration (PUV2008, or PUV2008 PUV2008 min or max) for the year

2008 will be reduced by the same number of percentage points, of which 95 have been reached

% values according to section 3.8.1, multiplied by the index (PUP2008-PUZamb2008)/

PUP2008.



3.10 If medical facilities reported and health insurance company

recognized by the number of points for performance granted under the ambulatory care per year

2008 will be less than 95% of the number of medical facilities reported


and health insurance company recognized for performance granted under

out-patient care for the year 2007, the resulting lump payment (PUV2008,

where appropriate, the min or max PUV2008 PUV2008) for the year 2008 shall be reduced by the same

the number of percentage points, of which 95% of the value has not been achieved in accordance with section

3.8.2, multiplied by the index of the PUZamb2008/PUP2008. For the purposes of calculating the number of

points referred to in section 3.8.2 is reported in connection with the performances of the day

care on a bed, according to the list of services considered as provided in the performance

the out-patient care.



3.11 the resulting lump payment (PUV2008, or PUV2008 min or

PUV2008 max) is reduced by the sum of the points calculated in points

3.9 and 3.10.



4. where in the clinic of changes in scale and

the structure provided by the paid care in comparison with the year 2007, and health

the insurance company will approve these changes, taking into account the contract, including

quantifying the increase (reduction) payments.



5. Health insurance shall take into account the change in the volume of reported and health

insurance company recognized by the extremely costly healthcare provided in

2008 compared to 2007, when this care is not covered in any other way.

Extremely costly health care for the purposes of this Ordinance means

healthcare provided to the insured person whose medical facility

the volume exceeds the amount of $ 1 0000 0000. To the volume of health care

counted separately charged medicines, especially the posted material

and the point value of the medical procedures according to the list of performances with the value

in accordance with § 2.



6. The flat-rate remuneration referred to in paragraphs 1 to 5 shall not include health care

provided by the insured from the EU. If this care on the basis of the contractual

the arrangement covered by list of performances, the point value is determined in § 2.



B) institutional care according to § 3 (2). 2



1. A flat rate per one day of hospitalization



a) flat rate for one day of hospitalization shall be determined for each

the category of the patient and the type of treatment the day alone, according to the list

performance and includes the value of the respective treatment delivery, including Director

assigned to ošetřovacímu date and category of the patient, according to the list

the performances, by the standard amount that is payable under section 17 of the medicinal products

paragraph. 7 of the Act and medical procedures, which shows income and

layoff examination referred to in the list.



(b) the amount of the flat-rate tariff for) one day of hospitalization is determined in the amount of

102% of the flat rate per treatment day belonging to a healthcare

with the exception of psychiatric specialised therapeutic institutes

returning the treatment days 00021 and list of performances, 0005 in

2007.



c) above the flat rate per day of hospitalisation in psychiatric

specialised therapeutic institutes, returning the treatment days 00021 and 00026

According to the list of performances shall be fixed at 103% of the flat rate per

treatment day belonging to a medical facility in 2007.



(d)) if the in the clinic of changes in scale and

the structure provided by the paid care in comparison with the year 2007, and health

the insurance company will approve these changes, taking into account the contract, including

quantifying the increase (reduction) payments.



2. Reimbursement of out-patient care, special care and special constitutional

care



and for outpatient health care) paid by performance list

point value determined in § 2.



(b)) for the special outpatient care provided under section 22 (b). (c))

the law, paid according to the list of performance shall be in the amount of point value

1.03.



(c)) for special care provided in health facilities

the hospice type according to § 22a of the law, paid according to the list of performances,

provides the value of the item in the amount of € 1.03.



C) regulatory restrictions



1. If the total remuneration for medicinal products and medical devices

prescribed by the medical device competent health insurance policy holders

insurance in 2008, with the exception of medical devices

the review by a doctor approved, exceeds 105% of remuneration for medicinal products

and medical devices prescribed in 2007, with the exception of

medical devices approved by the review by a doctor, medical

the insurance company within the total payment of the medical facility to reduce the payment

the amount corresponding to not more than 40% of such excess. In the total remuneration

will be included as well as supplements for medicinal products, for which the prescribing

the doctor has ruled out the possibility of replacement pursuant to § 32 para. 2 of the Act.



2. in the event that the medical facilities provided in 1. semester or in the

2. half of 2008 Healthcare 100 and less relevant to insurance policy holders

health insurance companies, health insurance does not apply the regulation referred to

in point 1.



Annex 2



The value of the item, the amount of the reimbursement of health care and regulatory restrictions pursuant to § 4



And kapitačně) combined the performance payment



1. the amount of the payment kapitační is calculated by the number of passenger policy holders

appropriate health insurance, multiplied by the base rate laid down

on one of the insured person is registered with the health insurance companies on the

calendar month. The basic rate according to the first sentence shall be at the rate of 42

CZK. The number of insured persons of the relevant health insurance companies ' profits are

calculated by multiplying the number of medical institutions registered

competent health insurance company policyholders age

the groups referred to in point 4, the index referred to in section 4 of romanticism. The amount of the basic

rates, where applicable, the total amount of the payment may be increased when the

the conditions laid down in the contract between the health insurance company and

the medical establishment. This increase must not be contrary to the health

premiums health insurance plan.



2. for medical procedures not included in kapitační payments, health

performances to be unregistered, the competent health insurance company and the insured person for

the insured person from the EU, the medical establishment declared and health

insurance recognised, by the list of performance shall be the value of the

point in the amount of CZK 1.



3. for the performance of the transport in the visitors service, paid for by list of performances

down the point value of 0.91 Eur.



4. Index expresses the ratio of the cost of insured persons in the age group

against the costs of insured persons in the age group 15 to 19 years of age.



Age group and indexes:

+----------------+-------+

| Age group | Index |

+----------------+-------+

| 0-4 years | 3.80 |

+----------------+-------+

| 5-9 years | 1.65 |

+----------------+-------+

| 10-14 years of age | 1.30 |

+----------------+-------+

15-19 years, | | 1.00 |

+----------------+-------+

20-24 years, | | 0.90 |

+----------------+-------+

| 25-29 | 0.95 |

+----------------+-------+

30-34 years, | | 1.00 |

+----------------+-------+

35-39 years, | | 1.05 |

+----------------+-------+

40-44 years, | | 1.05 |

+----------------+-------+

45-49 years, | | 1.10 |

+----------------+-------+

50-54 years, | | 1.35 |

+----------------+-------+

55-59 years, | | 1.45 |

+----------------+-------+

60-64 years, | | 1.50 |

+----------------+-------+

65-69 years, | | 1.70 |

+----------------+-------+

70-74 years, | | 2.00 |

+----------------+-------+

75-79 years, | | 2.40 |

+----------------+-------+

80-84 years, | | 2.90 |

+----------------+-------+

85 years and over, | | 3.40 |

+----------------+-------+



(B)) the combined kapitačně output with payment by calling kapitace



1. the amount of the payment by calling kapitační with kapitace is determined by (a).

And) point 1. Call kapitace is provided in cases where practical

a doctor for adults or general practitioner for children and adolescents has

on the geographical conditions, a small number of insured persons of the relevant health

the insurance company than the 70% of the national average in the number of insured persons

competent health insurance company (national average number of down

always for the calendar year according to data from the central registry

insured persons, managed by the General health insurance company of the United

the Republic) and the provision of such health care is necessary to meet the

duty of health insurance pursuant to § 46 para. 1 of the law.



2. Call kapitace can provide up to 90% kapitační payment

calculated on the nationwide average number of insured persons of the relevant health

the insurance company. He is involved in health insurance, with whom he has

medical equipment contract for the provision and payment of medical

care, which corresponds to the percentage share of its policy holders of registered

This medical institution from the total number of insured persons all

health insurance companies registered by the medical establishment.



3. For payment according to the list of performances with (a). A) points 2 and 3 shall apply

by analogy.



(C) health care paid by) the list of performances



For health care paid for by list of performances and for transport in the

Guestbook service, paid for by list of performance shall be the point value

in the amount of € 0.91.



D) regulatory restrictions



1. Regulations for the prescribed medicines and medical devices and

for the requested care in the fields of Medicine (listed in the requested care

do not include medical procedures carried out by the screening mammografického


the medical establishment, which has insurance on the

the provision of such medical procedures agreements):



1.1. If the average remuneration for medicinal products and medical

the means prescribed by the medical device related to one

equivalents of the insured person exceeds by more than 20% of the national average

remuneration for the prescribed medicines and medical devices, it is

health insurance company authorized to exercise regulatory reduction of up to 25% of the

the excess. The average payment per insured person is converted

includes the supplements for medicinal products, for which the prescribing

the doctor has ruled out the possibility of replacement pursuant to § 32 para. 2 of the Act.



1.2. If the average payment for the requested care in listed

specializations according to the list of procedures related to one the equivalised

of the insured person exceeds by more than 20% of the national average remuneration for the

pull the care in the listed fields of medicine, is a health insurance company

entitled to exercise regulatory reduction of up to 25% of the excess.



2. Regulatory constraints referred to in point 1.1 and 1.2 shall not apply, if

medical facilities justifying medical care provided on the

the basis has exceeded the average of payments referred to in point 1.1, where appropriate,

1.2.



3. Regulatory constraints referred to in point 1.1 and 1.2 shall further not apply if

medical device register in 2007 or 2008 50 and less

insured persons the competent health insurance company or has provided health care

50 and less non-registered persons insured the relevant health insurance

or in the case of healthcare provided to the insured from the EU.



4. Regulatory constraints referred to in point 1.1 shall not apply if the total remuneration

for all the medicines and medical devices prescribed by

General practitioners for adults and general practitioners for children and adolescents in

the year 2008 shall not exceed the estimated amount of the remittances to this kind of health

care for the year 2008 based on the health insurance plan of the appropriate

health insurance companies.



5. the regulatory restriction under section 1.2 shall not apply if the total remuneration

for the requested care in the listed fields of medicine in 2008, shall not exceed the

the estimated amount of remittances to this kind of health care for the year 2008

based on the health insurance plan of the appropriate health

the insurance company.



6. the insurer is entitled to assert regulatory reduction by

points 1.1 and 1.2 for a maximum amount corresponding to 15% of the volume of payments

provided in the health insurance medical facility for

kapitační payment and medical procedures, reduced by the amount of remuneration for particular

posted material and separately charged medicinal products for the year 2008.



Annex 3



The value of the item, the amount of the reimbursement and regulatory restrictions pursuant to § 5



And the point value and the amount) reimbursement



1. the amount of the remuneration shall be fixed according to the list provided by remuneration for performance

medical procedures-valued point of



and in 1.05 Eur) for healthcare facilities providing hemodialysis treatment,

for medical device reporting performance expertise-910

psychotherapy according to the list of performances together with the ošetřovacím the date of the daily

According to the list of performances



(b) $ 1.10) for health care facilities contracting expertise-901

Clinical Psychology, 903-927-clinical speech therapy and orthoptist,

According to the list of performances



(c)) $ 1 for all other health care facilities. In the cases specified in

section 6. (a). and you may pay the health insurance company) healthcare

equipment medical procedures for the expertise achieved in real terms the value of the

point multiplied by the index increase in remittances, laid down in point 2.



2. unless otherwise stipulated, the total amount of the reimbursement of medical

device



and providing health care in) one of the skill does not exceed

which is calculated as follows:



POPzpo x PUROo x In



where:



POPzpo number of unique insured persons treated in the

expertise of medical facilities in the relevant

half of 2008; unique by the insured person for the purposes of

This Decree means one insured person competent

health insurance companies treated in medical facilities

in that, at least in the corresponding half of the skill

Once, while not applicable, whether it is

about the treatment in the context of their own care or care requested.

If the insured person the medical establishment

in the expertise of the treated in the half-year

more than once, includes the number of unique policy holders

the health insurance companies treated in the

expertise only once



PUROo the average remuneration for medical procedures, including especially

the posted material and separately charged to medicinal

the one unique insured

treated in the expertise of the medical institutions

in the half-year, 2007

In the index increase in payments, which shall be at least 1.06



(b)) providing health care in multiple fields of medicine does not exceed the amount

equal to the sum of the amounts for individual expertise, where the amount of the

individual expertise is calculated as follows:



POPzpo x PUROo x In



where:



POPzpo number of unique insured persons treated in the

expertise of medical facilities in the relevant

half-year 2008



PUROo is calculated as follows:



PUROo = PPBROo x RDHB + PUZUMROo + PUZULPROo



where:



PPBROo average number of medical facilities declared and

health insurance company recognized points on one

the unique skill of the insured in the treated

the medical establishment in the half-year, 2007



RDHB realistically achieved point value for ambulatory

specialized care, provided by the medical

equipment for health insurance in the relevant

half of 2007, which is defined as the proportion of the total

the remuneration provided by the medical facility health

insurance for outpatient specialist care

reduced by the amount of remuneration for the separately posted material and

separately charged for the medicinal product

half of 2007 and the total number of points per out-patient

specialized care medical facilities

reported for the half-year 2007 and health

insurance company approved



PUZUMROo the average remuneration for the separately posted material on the

one of the unique expertise of an insured person in a given

a medical facility in the half-year, 2007



PUZULPROo the average remuneration of a particularly charged to medicinal products

one of the unique expertise of an insured person in a given

in a medical facility in the half-year, 2007



In the index increase in payments, which shall be at least 1.06



For medical devices, which in the reference period

did not exist, or that provides care in the

expertise, the health insurance company for the purpose of calculating the total

the amount of the payment of remuneration to the average use of one unique

of the insured person during a reference period of comparable health

device.



3. in the case of medical devices, where half of 2007 compared to the competent

the changes range from nasmlouvaného provided by the health care

some expertise (i.e. change the spectrum of the contracted performance)

the average payment per unique person, the amount of

payment of the medical device as defined in point 2, increased by the value of the

medical facilities and health insurance company declared the recognised

the newly contracted medical procedures, including especially the posted

material and separately charged to medicinal products. The newly contracted

the performances are for these purposes will be appreciated according to the list of performance using the value

the point of 0.95 €.



4. the insurer shall take into account cases where further medical

the device proves that increased the average cost of separately billed

material and separately charged medical preparations per one unique

of the insured person in a given skill were caused by changing the amount or the method of

their remuneration, or due to changes in the structure of the treated

policy holders.



5. Beyond the total amount of remuneration laid down in point 2. shall be borne by the health

insurance company provided health care according to the list of performances (including

especially the posted material and separately charged of medicinal products),

remuneration for provided medical procedures with the value of the point set out in the

the level of 0.30 €. The number of points covered by the this value is determined as the

the difference between the total number of medical facilities declared and

health insurance company recognized points and number of points, which is determined

as a proportion of the total amount of remuneration laid down in point 2., after deduction of the

medical facilities and health insurance company reported a recognised

especially the posted material and separately charged of medicinal products and

the point values laid down in point 1. c). If this difference has a negative

the value of, the provisions of this section shall not apply.



6. the provisions of paragraph 2. and (5). do not apply:



and) in the case of medical equipment as specified in point 1. (a). (c)), which in

the half-year 2007 or 2008, within a single expertise treating 50

and less unique policy holders when the contracted value of relative


the capacity numbers 1.00. The limit of 50 treated policyholders is unique

Converts the value of the IM capacity for the number of proportional

expertise. The relative simultaneously expresses the number size capacity

nasmlouvaného the scope of health care for the expertise provided by

one carries the performance ^ 3), the health insurance company,



(b)) at health care facilities contracting 901 (clinical skills

Psychology), 903 (clinical speech therapy), 927 (orthoptist)

medical device reporting health performance expertise 910

(psychotherapy), together with ošetřovacím day care centres and day

outpatient dialysis equipment expertise of 108 (Nephrology)



c) in the case of healthcare provided to the insured from the EU.



B) regulatory restrictions



1. Regulations for the prescribed medicines and medical devices and

for the requested care in the fields of Medicine (listed in the requested care

do not include medical procedures mammografického screening and screening

cervical cancer performed by the medical establishment, which has

the health insurance company on the provision of such medical procedures

concluded a contract):



1.1. If medical equipment reaches the average payment per

unique insured for the prescribed medicines and medical

resources in the corresponding half of 2008 higher than 110% of the average of the remuneration

one of the unique insured's prescribed medicines and

medical devices in the half-year 2007, health

the undertaking may medical facility, after the end of the year 2008, to reduce the

payment of the amount corresponding to 40% of the additional costs for the prescribed

medicinal products and medical devices (over 110%), and the ways in

contained in the contract of medical equipment and health insurance companies.

The average payment per insured person will be included as well as a unique

supplements for medicinal products, for which the prescribing doctor to exclude

the possibility of replacement pursuant to § 32 para. 2 of the Act.



1.2. If the medical device reaches the average payment per

the unique pull the insured's care in the listed fields of medicine in

the half-year 2008 higher than 110% of the average remuneration per

the unique of the insured person in the half-year, 2007, the health insurance company

can medical facility, after the end of the year 2008, to reduce the payment of the

the amount corresponding to 40% of the additional costs of the requested care (over 110

%), and ways the Treaty health care facility, and

health insurance companies.



1.3. the regulatory restriction referred to in point 1.1 and 1.2 shall not apply, if

medical facilities justifying medical care provided on the

the basis has exceeded the average of payments referred to in point 1.1, where appropriate,

1.2.



1.4. Regulatory constraints referred to in point 1.1 and 1.2 shall further not apply if

the total remuneration for the medical establishment to the prescribed medicines and

medical devices and pull the care in the listed

proficiency in the half-year 2008 will not exceed 105% of the total remuneration

in the half-year, 2007, and medical equipment in the

half of 2008 undergo at least 90% of insured persons against the unique

competent half-year 2007.



1.5. the regulatory restriction referred to in point 1.1 shall not apply if the total

payment for all the medicines and medical devices prescribed by

in the out-patient health care facilities providing out-patient

specialized care in 2008, shall not exceed the estimated amount of the remittances to

This kind of health care in the year 2008 based on the disabled

competent health insurance company insurance plan.



1.6. If, on the basis of the calculation of the regulatory restrictions according to point 1.1

or in accordance with section 1.2 should be health insurance asserted regulatory

reduction of more than 15% of the medical device, it shall

health insurance then the limits for the application of the relevant

regulatory constraints so that the number of health facilities with

rainfall does not exceed the calculated regulatory level of 15% of all

of the medical device.



1.7. in the case of medical devices, where half of 2007 compared to the competent

nasmlouvaného has changed the scope of medical services (changing number of

the holders of power authorized to prescribe medicines and

medical devices and require care in listed

fields of Medicine), in agreement with the health insurance company health

the average values of the device in the half-year 2007 remittances for the following

the purpose of a proportionally adjusted.



1.8. in the case of a medical device that in 2007 or in the part of the year

2007 did not exist, or not concluded a contract with health

the insurance company, health insurance company may use for the purposes of the application of the

regulatory restrictions referred to in points 1.1 and 1.2 of the reference value

comparable medical facilities.



2. If the medical facility treating in the half-year 2007 or

in the half-year 2008 in the expertise of 50 and less unique

policy holders when the contracted value of relative capacity numbers 1.00,

health insurance company this expertise does not include in the calculation of regulation under the

points 1.1 and 1.2. The limit of 50 treated policyholders is unique

Converts the value of the IM capacity for the number of proportional

expertise.



3. the regulatory restriction under section 1.2 shall not apply if the total remuneration

for the requested care in the listed fields of medicine in 2008, shall not exceed the

the estimated amount of remittances to this kind of health care for the year 2008

based on the health insurance plan of the appropriate health

the insurance company.



4. the insurer is entitled to assert regulatory reduction by

points 1.1 and 1.2 for a maximum amount corresponding to 15% of the volume of payments

provided in the health insurance medical facility for

medical procedures, reduced by the amount of remuneration for the separately posted material and

separately charged to the medicinal products for the year 2008.



Annex 4



Point value and the amount of the payments referred to in section 7 of the



1. The flat-rate remuneration



1.1 the flat-rate payment for 1. and 2. half of 2008 be set at 102%

the volume of payments for medical procedures, including especially the posted material and

separately charged of medicinal products, medical devices reported

and health insurance company recognized in the corresponding half of 2007. If it has been

medical device 1. or 2. half of 2007 health

insurance recognised and granted more than 102% of remuneration for the

half of 2006, without payment, points awarded by the coefficient of the variable

costs the amount of the flat-rate payment equal to the amount of the flat-rate remuneration for

the half-year 2007.



1.2 If a medical facility provides health care expertise

809 (radiodiagnostics) according to the list of performances as well as in other fields of medicine

referred to in section 7, provides for a flat-rate remuneration separately for expertise and 809

separately for other expertise.



1.3 If the medical device with the health insurance company contracted

89711-89725 performance according to the list of performances, the health insurance company

These performances from the flat-rate remuneration set aside and pay according to the list of performances with the

the value of the point, which is set at EUR 0.80 CZK.



1.4 after the evaluation of the total volume of provided health care in the

the half-year 2008 will modify the flat-rate health insurance

payment as follows:



and if the medical device reports) in the half-year 2008, the number of

, that health insurance will recognize, in the span of 98-102%

the reference to the number of points, the amount of flat-rate remuneration laid down in point 1.1:

does not change; the number of points of reference means the number of medical facilities

reported, health insurance company approved and paid in full

points in the half-year 2007. The number of reported points shall be included

only medical procedures that were medical institutions of health

the insurance company reported a 1. half of 2007 at the latest by 31 December 2005. October 2007 and

health insurance company recognized and paid until 31 December 2006. in December 2007, and in 2.

half of 2007, reported by 30. April 2008 and health

insurance recognised until 31 March 2006. May 2008,



(b) if the medical device reports) in the half-year 2008, the number of

, that health insurance company considers less than 98% of the reference

the number of points, the flat-rate remuneration referred to in point 1.1 shall be adjusted by multiplying the

coefficient of performance changes, which shall be calculated as the proportion of reported and

recognised by the number of points in the half-year 2008 and the reference number of

,



(c) if the medical device reports) in the half-year 2008, the number of

, that health insurance company must recognize a higher than 102% of the reference

the number of points, it modifies the health insurance a fixed remuneration as follows:



PB

UPS = PS + [(PS-x------------PS) x PKvn]

RPB



where:



UPS modified flat-rate remuneration

The flat-rate remuneration determined in accordance with PS 1.1 and 1.2

PB number of medical facilities declared to the points for

the half-year 2008 health insurance

recognised

RPB reference points

PKvn average variable costs


PKvn coefficient is determined for the expertise of 809

0.7 and other expertise in the amount of 0.5.



1.5 To the flat-rate remuneration referred to in points 1.1 to 1.4, the health

care provided to the insured from the EU, the contracted performance mammografického

screening and cervical screening.



1.6 If medical equipment has provided the half-year, 2007

health care less than 100 unique treated the insured or not

establish a fixed remuneration shall be provided by the health care

According to the list. The value of the point are set out in point 2.



2. Health care was paid according to the list of performances



2.1 for the contracted performance mammografického screening and health

care provided in 809 by list of performance skills, paid for by

list of performance shall be the point value in the amount of $ 1.07.



2.2 for the contracted cervical screening performance, paid by

list of performance shall be the point value in the amount of CZK 1.



2.3 for healthcare provided in the fields of medicine, 801, 802 222, 804,

805, 807, 812-819, 822 and 823, according to the list of performances, paid by

list of performance shall be the point value of 0.89 €.



2.4 For the contracted performance 89711-89725, according to the list of performances

paid by list of performance shall be the point value amounting to 0.80 CZK.



2.5 for healthcare provided to the insured from the EU, paid by

list of performance shall be the value of the point referred to in 2.1 to 2.4.



Annex 5



Point value and the amount of payments under section 8



1. the value of point is determined in the amount of $ 1.11 for ambulatory health care

a device that provides medical care in the expertise of 925 with the availability of 24

hours 7 days a week.



2. Point value shall be fixed at Eur 0.94 for ambulatory health care

device



and skill, 911)



(b)) that do not provide health care in the expertise of 925 with the availability of 24

hours 7 days a week.



3. for health care provided in 921, the value of the skill point

down in the amount of CZK 1.



4. For transport in the visitors service, paid for by list of performances

the value of the point set at EUR 0.91 Eur. These performances not covered by the

the provisions of points 5. and 6.



5. the health care provided by the medical establishment to 110%

the calculated volume modified, as appropriate, in accordance with section 7, shall be paid by the

list of performances with the value of the point referred to in points 1 to 3. This volume is

calculated as follows:

POPho

PBro x--------------

POPro



where:



PBro total number of medical facilities reported and

health insurance company recognized for the

half of 2007



The total number of unique POPho policyholders treated

the medical establishment in the half-year 2008



POPro the total number of unique policy holders treated

the medical establishment in the half-year, 2007



6. the health care provided by the medical establishment in the expertise of 925

over 110% of the volume calculated according to paragraph 5, where appropriate, adapted by

section 7, shall be paid to the value of EUR 0.43 € point, with respect to the provision of

health care availability 24 hours 7 days a week, in the other

cases in the fields of medicine and 911 925-valued point of 0.36 Eur and

921-valued skill point of 0.40 €.



7. If in the clinic of changes in scale and

the structure provided by the paid care in comparison with the year 2007, and health

the insurance company will approve these changes, taking into account the contract, including

quantifying the increase (reduction) payments.



8. The provisions of points 5 and 6 shall not apply if the health care facility

treating 50 and less unique policyholders in the half-year 2007.



9. Health insurance medical facility may arrange for monthly

interim payment either in the amount of medical facilities reported

and health insurance company recognized healthcare for any month, or

equal to one-sixth of the 103% of remuneration in the half-year, 2007

While the chosen form of health insurance will maintain throughout the

half of the year. A preliminary consideration for the half-year, health insurance

financially settles no later than 150 days after the completion of the relevant

half-year 2008.



Annex 6



Point value and the amount of the reimbursement in accordance with § 9



1. The value of the point shall be at the rate of 1.02 €.



2. for the performance of the transport in the visitors service, paid for by list of performances

the value of the point set at EUR 0.91 Eur. These performances not covered by the

the provisions of point 3.



3. for health care provided by the medical establishment over the calculated

volume, paid according to the list of performance shall be in the amount of point value

0.59 €. This volume is calculated as follows:

POPho

PBro x--------------

POPro



where:



PBro total number of medical facilities reported and

health insurance company recognized for the

half of 2007



The total number of unique POPho policyholders treated

the medical establishment in the half-year 2008



POPro the total number of unique policy holders treated

the medical establishment in the half-year, 2007



4. where in the clinic of changes in scale and

the structure provided by the paid care in comparison with the year 2007, and health

the insurance company will approve these changes, taking into account the contract, including

quantifying the increase (reduction) payments.



5. the provisions of paragraph 2 shall not apply if the health care facility and treating

50 and less unique policy holders in the appropriate half-year 2007.



6. Health insurance medical facility may arrange for monthly

a preliminary payment of either of the values of the medical establishment declared,

and health insurance company recognized by health care, for any month, or

equal to one-sixth of the 103% of remuneration in the half-year, 2007

While the chosen form of health insurance will maintain throughout the

half of the year. A preliminary consideration for the half-year, health insurance

financially settles no later than 150 days after the completion of the relevant

half-year 2008.



Annex 7



Point value and the amount of the reimbursement in accordance with § 11



1. The value of the point shall be



and in the amount of $ 0.94) for healthcare facilities providing health care

in continuous operation,



(b)) of 0.88 Eur for healthcare facilities to provide health

care in continuous operation.



2. the health insurance company may over 103% of the calculated volume adjust

the value of the point specified in the point. 1. for health care facilities

referred to in point 1. (a). and to 0.90 €), for health care facilities

referred to in point 1. (a). (b)) to 0.80 CZK. This volume is calculated as follows:



POPho

PBro x--------------

POPro

where:



PBro total number of medical facilities reported and

health insurance company recognized for year 2007



The total number of unique POPho insured persons who have been

in 2008, granted the right to health



POPro the total number of unique insured persons who have been

in 2007, granted the right to health



3. the provisions of paragraph 2, shall not apply to medical devices, which

2007 or 2008 has provided care for less than 50 unique insurance policy holders

competent health insurance company.



4. the health insurance company may provide medical facility for 1. and

2. half of 2008 interim payment equal to 103% of remuneration in

the half-year 2007.



1) Council Regulation (EEC) No 1408/71 of 14 June. June 1971 on the application of

of social security schemes to employed persons and their families

moving within the community and Council Regulation (EEC) No 574/72 of the Council

on 21 February 2006. in March 1972, laying down detailed rules for the application of regulation

(EEC) No 1408/71 on the application of social security schemes to

employed persons and their families moving within the community.



2) for example, the communication from the Ministry of Foreign Affairs No. 130/2002 Coll., m.

with the negotiation of the Treaty, between the Czech Republic and the Federal Republic of

Yugoslavia on social security, the communication of the Ministry of foreign

No 83/2000 Sb. m. s., on the negotiation of a Treaty between the Czech Republic and

The Republic of Croatia on social security, the Ministry of communication

Foreign Affairs No 135/2004 Coll., m. s., the negotiation of the agreement between the Czech

Republic and the Republic of Turkey concerning social security, communications

Ministry of Foreign Affairs No. 2/2007 Sb. m. s., the negotiation of the Treaty

between the Czech Republic and the Republic of Macedonia concerning social security.



3) Decree No. 134/1998 Coll. issuing the list of medical procedures

with point values, as amended.



4) section 10 of Act No. 526/1990 Coll., on prices, as amended by the Act No. 261/2007

SB.



5) the communication from the CZECH STATISTICAL OFFICE No. 309/2007 Coll., on the updating of the classification

hospitalized patients (IR-DRG).



6) Decree No 63/2007 Coll., on transfers of medicines and foods for special

medical purposes.